hg_183226.1

Basic information about the TSS

---

TSS ID: hg_183226.1 Species: human Chr: chr20		Start: 3795724 End: 3795859 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000467519.5 ENST00000245960.9 NM_001287519 NM_001287520 NM_001287522 NM_004358 NM_021873 NM_021872 uc061vdy.1 uc002wjn.5 AK092713 FR695900 FR695901 BX647988 BC051711 Distance: 0 GeneID: 994 HGNC/MGI_ID: HGNC:1726 UniProt_ID: B3KS38 E1YMX4 P30305 Q6MZW8

Gene_name: cell division cycle 25B Gene_symbol: CDC25B Gene_synonyms: Gene_source: HGNC:1726

TATA-Box annotation

---

Distance to TSS:	53
Nearest PromoterID:	NM_021872
Entrez ID:	994
Nearest Unigene:	Hs.153752
Nearest Refseq:	NM_004358
Nearest Ensembl:	ENSG00000101224
Gene Name:	cell division cycle 25B
Gene Alias:	-
Gene Description:	cell division cycle 25B
Gene Type:	protein-coding
CpG%:	0.09
GC%:	0.636816
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CDC25B p2@CDC25B p3@CDC25B p4@CDC25B p5@CDC25B p6@CDC25B p7@CDC25B p8@CDC25B
Sample		p1@CDC25B	p2@CDC25B	p3@CDC25B	p4@CDC25B	p5@CDC25B	p6@CDC25B	p7@CDC25B	p8@CDC25B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	70.52	10.71	3.31	0.78	2.53	2.14	0.78	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	58.07	10.32	3.64	0.20	2.43	1.01	1.42	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	56.71	8.68	1.93	0.39	2.12	2.12	2.51	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	50.94	9.98	2.49	0.00	1.46	1.46	0.62	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	50.17	11.92	2.47	0.45	1.80	0.67	1.35	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	53.88	8.33	1.16	0.00	1.16	1.94	0.78	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	80.62	14.38	2.61	0.44	2.40	2.40	2.83	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	78.48	14.29	2.18	0.24	2.66	2.42	1.45	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	77.58	15.82	2.56	0.00	2.56	1.92	1.71	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	82.31	6.96	3.48	0.58	1.74	4.06	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	80.04	9.30	4.04	1.21	0.81	3.64	2.83	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	79.68	6.10	1.22	0.41	0.81	4.47	2.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	5.64	1.61	0.81	0.00	1.29	0.48	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	2.86	1.80	1.95	0.15	1.05	0.00	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	3.51	1.76	1.54	0.22	0.88	0.44	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	2.77	0.75	1.76	0.25	0.75	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	3.28	1.53	1.09	0.00	0.44	0.22	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	1.27	2.53	1.27	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	4.27	1.07	0.53	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	4.06	0.30	1.05	0.00	0.75	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	2.27	0.94	1.34	0.00	0.94	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	3.80	2.07	1.38	0.17	0.35	0.17	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	2.84	0.39	1.42	0.00	0.90	0.26	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1.94	0.73	0.73	0.49	0.73	0.73	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	1.55	1.03	1.03	0.00	1.55	0.00	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	3.17	1.58	0.95	0.32	1.58	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	4.95	2.20	0.55	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	4.95	1.18	0.71	0.24	0.24	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	4.20	1.29	1.45	0.32	0.81	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	3.44	1.27	1.27	0.18	0.36	0.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	4.19	1.05	0.84	0.21	0.63	0.21	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	2.74	1.37	0.59	0.00	0.59	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	3.38	0.84	1.48	0.00	0.21	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	3.30	1.48	0.82	0.33	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	1.87	1.31	1.31	0.19	0.00	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	3.64	1.34	0.77	0.00	0.38	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	3.88	1.64	0.61	0.00	0.61	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	1.61	0.81	0.40	0.00	0.40	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	2.16	0.81	0.27	0.00	0.81	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	2.64	0.96	0.72	0.00	0.24	0.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	2.59	1.18	0.00	0.00	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1.76	1.76	1.02	0.00	0.15	0.59	0.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	1.48	1.05	0.42	0.00	0.42	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	3.85	0.70	0.87	0.00	0.52	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	2.01	1.00	0.20	0.00	0.20	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	1.86	0.00	0.23	0.23	0.23	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	2.16	0.96	0.72	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	2.98	0.60	0.60	0.00	0.89	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	1.91	0.72	0.48	0.00	0.24	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1.21	0.20	1.62	0.00	0.20	0.40	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	2.46	0.82	0.41	0.00	0.00	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	1.33	0.67	0.67	0.22	0.44	0.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	1.06	1.42	1.42	0.35	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	2.32	1.33	0.66	0.00	0.00	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	0.00	0.00	0.00	0.00	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1.84	0.46	0.46	0.00	0.00	0.00	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	2.27	0.65	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1.93	0.00	0.64	0.00	0.32	0.96	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1.57	0.94	0.00	0.00	0.00	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	1.41	0.00	2.12	0.00	0.71	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	1.12	0.56	1.12	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.96	0.80	0.00	0.00	0.00	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	2.04	0.00	0.68	0.00	0.34	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	2.60	0.32	0.32	0.00	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	1.42	1.42	1.06	0.00	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	1.46	1.46	0.00	0.00	1.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	1.49	1.49	0.00	0.00	0.50	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	0.94	1.88	0.94	0.00	0.47	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	1.99	0.99	1.66	0.33	0.33	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	2.78	0.00	1.86	0.31	0.31	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	1.83	2.14	1.83	0.00	1.22	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	2.53	8.55	0.48	0.32	0.16	0.16	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	2.25	8.34	0.32	0.00	0.16	0.32	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	2.29	8.27	0.25	0.13	0.25	0.13	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	9.72	2.24	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	0.00	9.38	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	0.00	4.47	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	5.50	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	0.90	9.94	0.00	0.00	0.00	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	6.43	6.60	0.52	0.00	0.35	0.17	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	22.88	12.71	2.93	1.17	1.17	0.59	0.59	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	12.10	12.10	1.54	0.77	0.51	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	24.25	11.71	4.18	0.84	0.84	0.56	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	7.64	2.94	1.76	0.59	0.00	2.94	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	7.56	10.30	0.56	0.24	0.16	0.24	0.48	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	19.69	12.59	0.32	0.32	0.00	0.32	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	7.46	9.60	0.53	0.00	0.00	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.57	4.45	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	0.83	9.15	0.00	1.25	0.42	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	8.29	10.55	0.50	0.50	0.00	0.50	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	4.58	5.24	0.33	0.00	0.33	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	3.65	3.65	0.61	0.30	0.00	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	20.77	4.64	0.88	0.44	1.10	0.44	0.22	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	20.08	9.32	1.79	0.00	2.87	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	4.79	0.00	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	19.07	16.37	9.53	1.08	4.68	0.54	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	10.04	10.04	0.00	3.35	1.67	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	13.15	11.51	5.55	0.21	3.90	0.41	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	37.65	6.64	5.38	1.03	2.63	0.57	0.69	0.00
Anulus Pulposus Cell, donor2	11463-119B5	40.16	6.86	5.39	0.49	1.22	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.49	2.25	1.35	0.45	0.45	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.91	6.08	1.30	0.43	0.87	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	5.38	4.18	0.60	0.00	0.00	0.30	0.30	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	5.06	1.26	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	1.32	0.66	1.32	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.15	5.20	0.65	0.32	0.00	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.28	3.88	1.46	0.49	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.13	2.38	1.19	0.00	0.59	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.52	4.90	0.75	0.38	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.81	6.53	1.45	0.00	0.00	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	3.76	1.25	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.24	3.13	0.82	0.33	0.49	0.16	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	10.92	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.37	4.98	1.21	0.30	1.06	0.00	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.82	4.29	0.00	0.54	0.54	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.23	5.10	1.32	0.00	0.94	0.19	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.08	5.35	0.80	0.00	0.27	0.27	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1.95	3.90	0.98	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.14	4.31	0.66	0.00	0.66	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	2.40	0.00	1.20	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.38	4.97	1.03	0.00	0.69	0.17	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	8.74	3.88	0.97	0.00	0.49	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	5.69	6.07	1.52	0.00	0.76	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	3.63	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	3.42	0.57	0.00	0.57	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.99	7.05	1.50	0.43	0.00	0.43	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.65	2.58	0.77	0.00	0.26	1.03	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.22	2.82	0.94	0.00	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.47	3.22	1.29	0.00	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	3.57	2.14	0.00	0.00	1.43	0.71	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1.75	2.92	0.00	0.00	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4.52	3.61	1.20	0.00	1.20	0.30	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	5.94	1.19	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.63	2.03	0.00	0.51	0.51	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.11	3.57	1.53	0.25	0.00	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.18	6.35	1.27	0.00	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.88	3.45	0.86	0.00	0.00	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.87	2.96	0.64	0.64	0.21	0.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.93	4.06	0.87	0.29	0.87	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	3.78	3.78	1.89	0.00	0.00	0.00	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.78	5.09	0.17	0.17	0.68	0.68	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	2.32	4.63	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	6.34	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.57	3.43	0.64	0.00	0.21	0.43	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.21	4.21	1.20	0.60	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	3.64	0.73	0.00	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.59	4.83	0.92	0.00	0.23	0.00	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	0.00	0.00	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.07	1.53	1.02	0.25	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.84	4.75	0.83	0.00	0.62	0.83	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	9.18	4.90	1.53	0.00	0.31	0.31	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.21	2.87	0.00	0.00	0.00	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.10	3.33	1.77	0.67	0.44	0.44	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	7.63	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.98	4.43	0.00	0.00	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.68	6.36	0.79	0.00	0.00	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.82	3.27	1.82	0.00	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	50.35	12.04	8.97	1.23	4.30	2.21	1.47	0.12
Astrocyte - cerebellum, donor2	11580-120F5	30.30	10.95	9.93	0.51	3.25	1.88	1.03	0.00
Astrocyte - cerebellum, donor3	11661-122F5	13.63	3.99	4.61	0.63	2.31	1.05	0.63	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	28.58	7.67	4.88	0.70	2.09	1.05	2.09	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	50.47	7.93	10.84	0.81	5.82	2.75	1.46	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	31.77	6.26	10.14	0.45	4.33	3.43	1.64	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	51.84	23.74	0.69	0.23	0.34	10.78	4.13	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	48.99	20.17	1.13	0.75	1.13	9.65	3.51	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	55.31	24.69	1.14	0.80	0.57	10.24	4.89	0.00
Basophils, donor1	12241-129G9	19.35	11.77	0.00	0.26	0.26	0.26	0.26	0.00
Basophils, donor2	12242-129H1	41.49	30.67	0.00	4.33	0.00	1.44	1.44	0.36
Basophils, donor3	12243-129H2	9.85	11.17	0.00	0.44	0.00	0.15	0.44	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	25.01	4.74	0.22	0.43	0.86	0.65	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	26.52	8.69	4.57	0.00	1.37	1.37	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	7.17	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	64.65	1.88	4.39	0.00	3.14	3.14	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	67.38	4.37	4.78	0.21	3.74	1.66	1.66	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	27.87	5.76	2.99	1.38	1.84	0.46	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	22.85	3.24	0.90	0.72	1.44	1.08	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	72.34	33.08	3.19	6.29	0.72	2.99	3.40	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	50.77	23.52	1.63	3.73	0.23	3.49	2.10	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	8.95	10.87	0.32	0.64	0.64	0.64	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	6.76	12.96	0.00	0.00	0.00	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	16.89	20.04	0.00	0.00	0.00	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	11.42	19.54	0.22	0.22	0.22	0.66	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	17.83	24.62	1.70	0.28	1.42	0.28	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	51.18	18.95	1.90	1.52	0.38	1.14	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	59.50	20.71	2.30	0.99	1.31	0.66	1.31	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	9.25	9.11	0.00	0.29	0.14	0.43	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	5.73	4.22	0.00	0.30	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	9.71	8.77	0.24	0.71	0.00	0.24	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.86	9.37	0.17	0.00	0.17	0.00	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.14	6.90	0.00	0.00	0.00	0.28	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.70	5.95	0.00	0.00	0.00	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.15	5.09	0.20	0.00	0.00	0.00	0.39	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.74	4.81	0.00	0.00	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	4.35	3.26	0.22	0.00	0.00	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.51	6.32	0.23	0.00	0.47	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.11	3.17	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	1.11	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.57	11.30	0.30	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.79	4.99	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.33	2.71	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.03	8.92	0.23	0.00	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.75	4.98	0.00	0.00	0.45	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	5.24	0.00	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.38	7.53	0.00	0.00	0.27	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.84	6.11	0.00	0.00	0.00	0.17	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.89	3.79	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.59	6.06	0.00	0.00	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.64	4.58	0.00	0.00	0.00	0.35	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.02	3.51	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.06	8.37	0.35	0.17	0.17	0.00	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.72	4.83	0.00	0.37	0.00	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	3.88	6.25	0.00	0.00	0.00	0.22	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.37	3.69	0.41	0.00	0.00	0.82	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.64	2.78	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.25	1.39	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	1.53	8.94	0.00	0.22	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	3.23	12.01	0.00	0.46	0.00	0.00	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	1.73	7.80	0.00	0.43	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	1.25	6.85	0.00	0.47	0.00	0.16	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	3.32	5.94	0.00	0.17	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.67	14.05	0.00	0.45	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	1.53	4.59	0.00	0.51	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	2.63	6.81	0.00	0.66	0.00	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	0.84	8.84	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	28.45	34.55	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.95	29.83	0.00	0.68	0.00	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	17.61	26.93	0.00	1.04	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	33.58	21.85	0.53	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	36.45	24.12	0.00	0.54	0.54	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	17.55	30.18	0.70	0.70	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.02	30.59	0.78	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	25.05	21.09	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	16.44	52.60	0.00	0.82	0.00	3.29	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	13.06	40.62	0.73	0.73	0.00	0.00	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	26.76	49.47	1.51	3.03	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	69.09	3.64	0.40	0.40	0.40	15.76	5.25	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	35.16	3.60	0.40	0.00	0.00	11.59	4.79	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	2.81	9.55	0.56	0.00	0.00	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	7.52	11.27	0.00	1.13	1.13	1.13	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	13.08	11.95	0.45	0.68	0.90	2.25	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	84.98	75.70	0.00	2.86	0.36	1.43	1.43	0.00
CD4+ T Cells, donor2	11306-117C1	116.35	75.93	1.22	0.00	0.61	1.84	2.45	1.22
CD4+ T Cells, donor3	11382-118B5	146.09	57.95	2.13	1.52	1.83	2.44	1.83	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	339.46	23.48	2.55	3.32	2.04	4.85	2.81	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	322.75	26.05	6.29	6.29	3.37	5.39	4.94	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	251.82	54.62	5.46	6.61	3.74	4.02	4.31	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	108.09	44.09	0.47	0.95	0.00	1.42	1.90	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	167.15	47.06	0.70	0.70	0.70	1.40	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	52.74	72.52	0.00	3.30	0.00	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	259.26	16.91	5.20	3.03	3.47	5.20	4.48	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	335.54	19.32	5.76	4.91	3.22	5.42	6.95	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	153.95	19.99	4.35	5.48	3.06	5.80	4.51	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	200.39	22.41	1.79	0.45	0.45	4.03	4.48	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	257.50	17.12	1.40	3.49	0.70	2.80	3.14	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	190.51	41.36	0.44	3.08	1.76	4.84	3.08	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	217.15	18.55	3.37	3.37	2.95	5.48	3.37	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	138.58	21.40	5.61	4.57	4.99	6.23	2.49	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	98.23	27.73	4.68	5.01	3.34	5.01	2.34	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	144.13	59.55	1.36	1.36	0.82	2.18	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	157.57	72.35	0.54	3.22	1.07	2.68	1.07	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	57.38	116.56	0.00	1.79	0.00	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	366.59	29.30	8.34	4.82	6.68	5.93	7.05	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	359.59	18.85	8.45	3.47	6.93	5.20	5.20	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	284.13	34.25	7.99	7.15	6.51	5.46	6.72	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	164.83	28.31	1.01	0.51	1.01	3.54	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	193.23	35.09	1.30	1.73	1.73	3.03	2.17	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	139.90	64.94	0.44	3.05	0.87	3.05	1.31	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	147.47	67.30	2.47	1.48	0.49	6.93	3.46	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	96.01	54.47	0.92	0.92	0.00	0.92	4.62	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	82.35	47.46	1.40	1.40	0.00	2.79	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	197.45	68.96	0.28	1.94	1.38	3.88	3.05	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	216.43	71.41	2.21	3.19	1.96	2.94	3.19	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	130.90	52.36	1.54	3.08	0.00	0.00	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	152.92	61.24	2.86	3.58	0.36	3.22	3.22	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	109.41	44.32	1.38	1.38	0.00	2.77	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	104.44	81.52	0.65	2.95	0.33	1.31	0.65	0.65
CD8+ T Cells, donor2	11307-117C2	85.22	69.08	1.13	1.50	0.75	1.13	1.13	0.75
CD8+ T Cells, donor3	11383-118B6	70.44	89.89	1.01	2.02	2.27	1.01	1.01	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.36	39.46	0.00	0.92	0.00	0.92	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.59	36.67	0.48	0.72	0.48	0.24	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.01	40.49	0.00	0.27	0.00	0.55	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.60	50.44	0.60	0.60	0.60	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.24	39.36	0.48	0.48	0.72	0.24	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.14	43.20	0.45	0.45	0.45	0.45	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.69	38.89	0.65	0.65	0.22	0.43	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.37	37.64	0.53	0.53	0.00	0.53	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.57	36.12	0.23	0.70	0.23	0.94	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	7.85	41.36	0.00	0.30	0.30	0.60	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	9.01	39.80	0.00	0.29	0.87	0.58	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.12	38.10	0.53	0.80	0.27	0.80	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.69	31.52	0.00	0.44	1.31	0.44	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.94	25.50	0.00	0.91	0.91	1.37	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	16.41	23.12	1.49	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.68	37.46	0.00	0.72	0.36	1.08	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.01	37.69	0.00	0.29	0.00	0.00	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.24	34.65	0.71	0.71	0.24	0.71	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	6.65	47.22	0.32	0.95	0.63	0.63	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.69	42.14	0.00	0.92	0.62	1.23	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	8.66	42.96	0.32	1.92	0.32	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.80	40.16	0.76	0.00	1.15	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	6.31	33.89	0.00	0.00	0.39	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	8.32	30.26	0.00	0.00	1.51	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.09	28.10	0.00	0.00	0.00	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	22.38	27.28	0.00	0.00	0.00	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	48.08	1.00	0.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	74.94	7.31	1.83	3.66	1.83	1.83	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	16.80	6.42	4.45	0.99	1.98	0.99	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	11.47	4.21	2.00	0.21	0.84	0.53	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	133.47	5.20	15.95	0.00	6.93	2.08	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	13.50	8.53	2.49	0.00	1.07	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	12.40	9.33	1.59	0.57	1.14	0.34	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	8.06	22.38	3.58	0.00	1.79	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.90	10.92	1.62	0.40	0.81	0.40	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	23.53	5.97	5.39	0.23	2.41	1.61	1.38	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	8.34	5.34	1.50	0.00	0.64	0.64	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	13.45	6.02	2.39	0.27	1.42	2.04	0.35	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	18.52	14.49	1.01	4.95	0.37	0.46	0.83	1.47
Corneal Epithelial Cells, donor1	11526-119I5	27.01	4.83	2.42	0.44	2.85	0.44	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	22.75	5.69	2.28	3.41	2.28	1.14	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	50.87	5.62	6.14	0.26	5.88	3.07	2.05	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.32	14.69	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.95	11.99	0.00	0.32	0.00	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.43	13.39	0.00	0.11	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	2.05	6.15	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1.31	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1.94	5.81	0.00	0.48	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	17.01	13.51	1.67	0.33	1.17	0.67	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	19.95	8.80	1.17	0.59	0.59	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	26.58	6.50	7.35	0.57	0.85	1.13	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	13.76	9.83	1.18	0.00	1.18	0.39	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	9.60	9.89	1.75	0.29	0.29	0.58	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	11.76	8.94	1.18	0.00	1.18	1.18	0.94	0.00
Endothelial Cells - Artery, donor3	11413-118E9	18.06	13.67	3.68	0.18	1.58	2.28	0.70	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	14.85	13.52	1.11	0.66	0.44	0.66	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	29.21	15.21	1.83	1.52	0.91	0.30	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	13.53	12.12	1.13	0.56	0.56	0.00	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	12.78	10.99	7.13	0.00	2.67	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	21.87	2.60	2.60	0.00	2.60	1.04	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	38.28	11.06	9.93	0.43	3.40	0.57	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	44.41	17.61	6.80	0.00	3.20	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	2.62	7.86	2.10	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	38.52	14.79	5.47	0.62	3.35	2.24	1.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.49	11.51	6.08	0.22	6.95	3.91	2.82	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	53.74	13.68	6.72	0.12	5.13	2.93	1.95	0.00
Endothelial Cells - Vein, donor1	11267-116G7	26.16	4.55	0.00	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	12.57	12.57	1.40	0.00	0.70	0.00	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.58	9.11	2.51	0.63	1.41	1.73	0.16	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	6.60	1.65	0.00	0.00	0.00	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	55.95	3.42	1.47	0.98	1.71	0.73	1.47	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	3.28	5.75	0.82	0.41	1.23	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.21	1.97	2.41	0.00	0.44	0.00	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	50.27	5.85	8.23	0.76	2.17	0.54	0.87	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	20.74	4.37	4.00	0.73	1.21	0.24	0.85	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	44.90	12.01	3.96	0.68	1.50	0.41	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	63.28	6.33	8.96	0.42	1.69	0.74	1.27	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	89.85	13.17	9.49	0.53	1.84	2.11	1.05	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	84.05	9.97	9.30	0.66	2.99	1.33	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	29.49	4.99	4.08	0.00	0.91	0.45	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	7.58	3.03	0.00	0.00	1.52	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.57	11.20	0.32	0.00	0.63	0.16	0.63	0.00
Fibroblast - Cardiac, donor4	11452-119A3	90.93	19.40	9.09	0.61	2.12	3.03	1.82	0.00
Fibroblast - Cardiac, donor5	11456-119A7	68.40	7.36	9.01	0.63	3.68	1.02	0.89	0.00
Fibroblast - Cardiac, donor6	11460-119B2	49.12	14.25	12.28	0.30	3.18	1.67	0.61	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	26.93	16.88	3.22	0.54	1.34	0.40	0.54	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.08	11.65	0.86	0.00	0.86	0.43	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	4.39	0.00	0.00	1.46	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	116.70	20.99	22.60	0.69	7.84	2.54	1.85	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	249.66	11.02	17.47	1.19	4.58	0.85	1.19	0.17
Fibroblast - Dermal, donor1	11269-116G9	15.50	8.69	1.88	0.23	0.94	0.47	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	40.09	3.77	9.91	0.00	2.36	1.42	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	15.47	10.64	2.90	0.24	2.18	0.12	0.60	0.00
Fibroblast - Dermal, donor4	11450-119A1	31.65	7.80	10.06	0.57	5.43	1.81	1.24	0.00
Fibroblast - Dermal, donor5	11454-119A5	35.76	8.02	11.69	0.35	5.41	2.97	0.87	0.17
Fibroblast - Dermal, donor6	11458-119A9	36.55	9.26	10.72	0.16	6.33	1.62	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	51.02	6.04	8.95	0.42	4.58	0.42	1.04	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	52.66	11.00	7.07	0.26	3.14	1.31	1.31	0.26
Fibroblast - Gingival, donor2	11318-117D4	81.84	8.04	19.11	1.19	5.27	2.11	1.32	0.40
Fibroblast - Gingival, donor3	11394-118C8	116.80	8.99	23.40	1.74	5.80	1.74	2.13	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	12.47	7.27	0.00	3.12	1.04	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	52.16	4.76	7.75	0.00	1.41	1.06	1.23	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	68.44	12.00	18.08	0.31	5.61	1.40	1.71	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	48.41	8.65	15.42	0.81	4.60	0.81	1.08	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	129.15	22.58	19.41	0.35	10.23	2.47	2.47	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	91.55	7.60	15.79	0.29	5.12	1.61	1.02	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	88.36	9.27	11.18	0.68	5.59	2.45	3.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	70.75	8.56	20.73	0.11	7.90	1.43	1.65	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.51	11.15	7.04	0.59	1.47	0.73	2.05	0.00
Fibroblast - Lung, donor1	11270-116H1	21.75	8.16	4.08	0.00	1.36	2.72	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	77.59	23.87	13.43	1.49	1.49	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	85.26	10.55	12.45	0.84	6.12	3.80	1.48	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	67.47	30.82	13.33	2.50	6.66	3.33	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	11.19	8.39	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	10.08	7.00	3.36	0.00	1.40	0.84	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	30.04	36.13	6.09	0.00	3.65	0.81	1.62	0.00
Fibroblast - Mammary, donor2	11620-122A9	39.94	27.96	3.99	0.00	11.98	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	17.87	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	64.98	7.76	14.16	1.36	6.60	1.55	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	112.55	9.25	18.66	1.52	9.10	2.88	4.25	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	64.87	9.18	14.99	0.92	6.12	1.22	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	41.60	11.45	10.69	0.00	1.91	0.76	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.55	6.48	3.51	0.27	1.08	0.27	0.81	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	42.33	6.96	7.42	0.35	2.09	0.70	0.81	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	21.22	9.06	3.21	0.33	1.55	1.22	0.66	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	74.37	9.55	8.94	0.00	6.30	2.84	1.22	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	36.75	9.35	12.70	1.34	4.01	2.67	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	21.35	13.05	7.12	1.19	5.54	1.58	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	43.66	18.46	9.33	0.20	0.79	0.60	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	6.93	7.64	1.24	0.36	0.18	0.36	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	6.90	9.07	0.39	0.39	0.20	0.00	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	48.14	15.04	6.92	0.30	5.11	0.60	1.50	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	28.61	9.82	3.13	0.43	1.19	0.11	0.65	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.09	14.68	2.53	0.51	0.25	0.51	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	11.32	8.04	1.15	0.00	0.66	0.33	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	43.11	14.84	6.02	2.01	3.41	1.60	0.80	0.00
Fibroblast - skin normal, donor2	11561-120D4	26.72	6.83	2.71	0.20	1.61	0.90	0.30	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	42.92	12.39	7.86	0.91	4.23	0.60	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	8.04	8.04	1.91	0.25	0.41	0.33	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	43.76	11.97	3.76	1.37	0.34	0.51	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.60	18.72	4.27	0.99	1.31	0.99	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	37.07	6.18	4.37	0.32	1.07	0.43	0.64	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	42.68	7.76	6.92	1.01	3.20	0.67	0.51	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.49	3.76	1.25	0.00	0.16	0.16	0.47	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	44.32	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	3.49	0.00	2.61	0.87	1.74	2.61	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	21.84	3.81	2.08	0.35	0.87	0.17	0.52	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.60	6.25	1.56	0.52	1.56	0.78	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	52.12	4.85	2.30	0.00	3.07	0.26	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	8.42	6.89	0.00	0.77	0.77	2.30	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	4.47	5.10	1.28	0.64	0.64	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	11.70	12.55	0.29	0.29	0.86	2.28	1.71	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	8.82	0.55	1.65	0.00	1.10	3.31	1.10	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	8.68	1.60	1.14	1.14	2.51	1.83	1.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	10.30	6.93	0.59	0.40	0.59	2.58	3.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	7.40	0.79	1.32	0.26	1.59	2.91	2.11	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	6.20	1.63	2.61	1.63	1.96	0.65	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	13.27	3.10	0.44	0.88	0.44	1.77	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.84	3.67	0.99	0.00	1.27	2.83	1.55	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	14.90	2.46	1.48	0.37	2.83	3.20	1.23	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	10.21	4.30	0.54	0.27	0.54	3.22	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	12.76	4.21	2.11	0.12	2.35	1.98	0.87	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	11.49	3.60	2.21	0.14	2.77	1.52	1.38	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	9.15	2.85	1.42	0.00	2.44	1.63	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.43	2.28	4.11	0.23	3.88	1.60	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.33	3.86	3.61	0.37	5.23	1.25	0.75	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	18.80	2.19	2.19	0.22	4.37	3.06	1.31	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	16.84	3.84	2.95	0.00	3.84	1.48	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	11.60	1.59	2.86	0.16	3.66	2.07	1.43	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	13.41	2.90	2.90	0.45	1.79	1.34	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	22.78	5.04	6.86	0.40	4.64	2.42	1.41	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	18.83	3.39	4.24	1.19	2.54	2.54	1.70	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.88	4.34	3.37	0.18	3.55	2.31	0.71	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	40.48	7.70	8.12	1.04	5.62	2.29	1.14	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.96	8.03	6.49	1.20	4.44	2.22	1.20	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	25.34	4.43	4.87	0.77	2.88	1.77	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.04	4.41	4.41	0.75	2.41	1.08	1.16	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.40	3.06	3.06	0.41	3.47	1.23	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	20.01	3.30	5.36	1.86	2.89	1.03	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.06	3.80	5.19	1.04	3.69	0.81	1.84	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	23.35	5.67	6.50	0.83	2.84	2.00	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	14.77	4.41	6.83	0.88	3.75	0.44	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	16.23	4.55	5.29	0.74	3.32	1.35	1.35	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	30.64	6.32	5.19	0.49	3.57	1.78	1.46	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.41	3.53	5.13	0.96	4.49	1.28	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	18.29	6.16	6.06	1.23	2.84	1.61	1.14	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	24.68	6.01	7.59	0.63	7.59	2.37	1.42	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	21.89	6.99	6.69	3.95	4.87	2.43	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	16.62	4.70	6.06	1.05	2.61	1.46	1.15	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.74	5.05	7.46	1.10	2.63	1.32	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.02	10.10	10.10	0.28	3.09	1.12	1.68	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.30	8.80	6.30	1.20	2.13	1.67	0.93	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.02	8.29	6.69	1.07	4.55	1.87	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	27.23	9.03	7.19	0.92	5.05	1.99	1.38	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.67	9.33	5.18	1.17	2.07	1.81	1.42	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.02	10.30	10.30	1.36	2.98	1.08	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	29.13	6.82	7.01	1.29	3.50	0.74	1.66	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.41	6.36	4.82	1.97	4.39	1.10	2.19	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	39.67	16.86	6.94	1.98	4.96	2.98	2.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.82	7.65	8.44	0.53	2.24	2.64	2.11	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	34.50	5.65	10.29	0.81	2.02	1.21	1.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	69.64	41.94	7.62	3.81	3.30	2.54	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	16.52	6.57	0.60	0.20	0.60	2.79	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	13.40	3.08	0.46	0.15	0.62	3.24	2.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	16.37	6.14	0.61	0.00	1.23	5.11	2.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.01	5.32	0.00	0.63	1.25	0.31	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.52	3.39	0.28	0.57	0.85	1.13	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	6.00	6.92	0.92	0.92	0.00	3.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	7.42	0.00	0.00	2.47	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.90	4.64	1.16	0.00	1.16	3.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	6.42	4.81	0.00	0.00	0.00	0.00	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	6.96	5.22	0.00	0.00	0.00	8.69	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	7.49	2.93	0.65	0.33	0.65	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	10.71	4.94	0.82	0.41	1.24	1.65	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	10.00	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	5.31	2.80	0.84	0.56	0.28	1.12	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4.90	6.86	0.33	0.33	2.29	1.63	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	6.71	0.84	0.00	1.68	3.36	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	4.45	4.45	0.64	0.00	0.64	1.59	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	5.77	3.06	1.36	0.68	1.36	2.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	0.00	2.09	0.00	0.00	8.35	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	14.89	2.29	0.57	0.57	0.57	0.00	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.95	2.37	1.78	0.59	0.89	1.78	1.48	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	10.16	5.08	0.00	0.00	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	4.56	4.14	0.41	0.41	2.07	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	7.82	3.22	0.69	0.46	1.15	1.15	0.92	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	0.00	0.00	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	5.77	1.54	3.46	0.38	1.92	1.54	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	4.56	2.93	1.63	0.00	0.65	0.65	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.03	4.68	4.01	0.67	0.00	0.67	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	10.79	2.31	1.16	0.39	0.77	1.54	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	8.56	5.48	1.37	0.00	2.05	2.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	2.48	2.48	0.00	0.00	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.91	1.42	2.83	0.47	2.83	1.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	14.48	5.43	1.81	0.60	1.81	3.02	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	7.63	4.58	2.03	1.02	3.05	2.54	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	8.77	6.38	0.80	0.40	0.80	1.60	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	10.85	3.45	2.96	0.49	0.49	0.00	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	4.72	3.54	1.18	0.00	1.18	2.36	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	8.17	1.75	0.58	1.17	2.33	1.17	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	14.04	2.19	3.07	0.44	1.32	1.32	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	6.78	3.39	0.85	0.85	0.85	0.85	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.15	1.79	1.79	0.60	1.19	1.79	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.28	3.40	1.46	0.49	0.49	1.46	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	5.71	4.57	0.00	0.00	0.00	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	55.30	4.99	3.74	1.25	1.66	1.25	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	66.34	17.99	14.62	1.12	3.37	4.50	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	3.81	10.47	2.54	0.63	0.32	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.60	4.60	1.25	0.42	0.42	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	33.54	2.90	2.67	1.28	2.20	1.86	2.20	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	36.12	2.70	4.05	2.03	1.01	1.35	0.84	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	32.31	1.14	3.19	1.37	2.28	1.82	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	33.23	2.84	2.84	0.77	1.64	1.64	2.30	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.74	2.79	2.36	1.72	1.93	1.72	1.50	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	28.63	1.72	3.01	1.72	2.15	1.08	0.86	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.87	1.62	2.86	1.87	1.87	1.99	1.37	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	31.05	2.06	2.40	2.06	1.03	1.37	1.54	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	29.47	2.24	3.20	0.96	1.60	0.64	1.28	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	60.44	10.07	4.48	0.00	2.24	2.24	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	14.71	12.12	8.66	0.43	1.73	1.73	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	10.58	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.11	16.58	4.59	1.06	1.06	1.41	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	14.53	10.90	10.90	0.73	2.18	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	45.81	6.64	5.25	0.52	2.97	1.57	0.70	0.00
Hepatocyte, donor1	11523-119I2	4.84	9.68	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	7.54	19.39	1.08	2.15	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	8.59	11.66	0.61	0.61	0.00	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	165.13	56.78	2.61	20.23	3.92	13.71	5.22	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	18.70	3.67	2.10	1.05	0.87	0.70	0.70	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.72	4.53	0.55	0.14	0.69	1.10	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	9.55	3.18	0.00	0.00	9.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00	0.00	6.68	13.35	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	54.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	9.69	1.38	0.00	4.15	8.31	6.92	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	12.51	0.00	0.00	2.50	5.01	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	11.87	0.00	23.74	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	10.25	2.56	0.00	0.00	15.38	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	0.00	0.00	0.00	4.57	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	4.87	1.62	0.00	3.25	12.99	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	6.67	0.00	0.00	0.00	3.33	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	33.09	5.29	0.00	0.00	3.97	11.91	10.59	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	19.96	13.30	1.11	1.11	2.22	1.11	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	0.00	0.00	5.24	10.48	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.97	8.82	0.00	1.26	1.26	3.78	3.78	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	6.19	0.00	0.00	1.55	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	0.00	0.00	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	20.03	7.11	0.00	0.00	0.65	7.75	5.17	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	20.93	0.00	1.61	0.00	8.05	9.66	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	19.56	14.67	0.00	0.00	2.44	5.70	4.07	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	23.09	9.66	0.84	0.84	2.94	4.20	2.52	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	12.06	1.61	0.00	1.61	8.84	5.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	22.16	4.62	0.92	0.00	1.85	6.46	5.54	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	10.86	7.08	0.00	0.00	1.42	3.30	1.89	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	12.70	9.98	0.00	0.91	1.81	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	11.84	8.61	0.00	0.00	2.15	5.38	7.53	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	20.33	11.43	1.27	0.00	5.08	6.35	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	24.87	9.57	0.64	0.00	2.55	7.01	2.55	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	5.47	0.00	0.00	3.65	12.76	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	15.80	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.00	8.57	0.00	0.00	0.71	7.85	7.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	16.59	6.64	0.00	3.32	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.04	8.64	0.62	0.00	0.93	6.17	3.40	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	10.54	1.76	1.76	0.00	7.02	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	9.43	3.14	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	7.65	10.43	0.70	0.00	2.09	6.26	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	11.07	0.00	0.00	2.21	8.85	11.07	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	19.45	0.00	0.00	3.24	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	18.31	12.21	0.00	0.00	0.87	8.72	6.10	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	36.00	15.75	0.00	0.00	0.00	11.25	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	13.94	3.48	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	18.14	16.00	0.00	0.00	3.20	13.87	7.47	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	9.70	1.39	0.00	0.00	6.93	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	14.25	0.00	0.00	2.85	5.70	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	14.73	0.00	0.92	0.00	11.05	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	0.00	3.03	3.03	3.03	6.05	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	31.04	0.00	0.00	0.00	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	17.98	13.75	0.00	0.00	2.11	9.52	8.46	0.00
Keratinocyte - epidermal, donor1	11272-116H3	25.79	3.84	1.80	0.33	1.06	0.24	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	42.75	3.51	4.69	0.00	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	31.62	1.61	2.18	0.09	2.75	1.23	1.51	0.00
Keratinocyte - oral, donor1	11251-116E9	54.26	5.11	4.43	0.91	2.50	1.25	1.48	0.23
Keratocytes, donor1	11527-119I6	105.90	13.41	31.63	0.69	6.19	2.41	0.00	0.00
Keratocytes, donor2	11607-120I5	31.64	11.72	12.89	0.00	1.17	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	58.09	2.77	20.95	0.59	4.35	0.79	0.99	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	171.44	6.59	8.79	0.00	8.79	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	6.47	3.24	3.24	0.00	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	62.28	9.11	8.30	2.65	1.73	0.58	0.58	0.23
Lens Epithelial Cells, donor3	11690-122I7	1.31	3.53	0.61	0.10	0.30	0.10	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	59.76	9.25	4.62	0.47	2.37	0.71	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	38.51	6.42	6.14	0.28	5.86	1.12	1.67	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	67.53	6.77	5.82	0.47	2.05	0.79	1.57	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	24.20	6.99	4.84	0.54	2.69	1.61	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	45.70	6.93	8.19	0.32	4.41	0.95	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	53.91	5.28	5.82	0.11	1.51	0.86	1.29	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.91	7.39	3.28	0.00	2.05	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	47.78	6.07	5.81	0.25	4.55	0.76	1.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	49.54	6.90	5.49	0.56	2.82	0.99	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	30.46	6.33	5.54	0.00	0.79	0.79	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	49.63	4.85	7.37	0.78	2.33	0.58	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	42.21	3.89	6.30	0.00	2.78	0.93	0.93	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	28.22	6.62	3.48	0.35	2.44	1.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	50.33	5.96	6.68	0.48	3.10	0.72	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	42.72	4.67	5.77	0.14	4.40	1.37	0.55	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	32.95	4.62	4.31	0.31	1.54	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	40.84	4.36	3.74	0.31	2.18	0.31	1.25	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	50.87	6.59	5.31	0.18	2.74	1.28	0.73	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	24.35	8.56	3.95	0.00	2.63	0.33	1.65	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	39.83	6.15	7.32	0.29	4.39	1.17	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	54.76	8.46	7.72	0.50	1.99	0.75	1.49	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	25.22	5.33	3.88	0.00	0.97	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	39.32	5.12	4.85	0.00	2.42	0.27	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	46.62	6.06	4.69	0.00	2.12	0.91	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	24.37	3.11	4.67	0.52	2.07	0.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	44.81	7.12	4.40	0.21	2.09	0.42	1.26	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	46.46	5.41	4.66	0.45	2.26	0.75	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	33.02	4.82	5.50	1.38	2.75	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	43.09	3.95	5.08	0.00	2.45	0.94	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	48.35	7.95	4.56	0.00	1.48	0.85	0.64	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	34.89	13.57	1.94	0.97	2.42	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	35.39	3.31	5.95	0.66	3.64	0.66	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	49.06	5.45	5.58	0.37	2.60	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	23.32	8.51	5.55	0.00	2.59	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	34.10	4.69	2.72	0.00	4.20	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	35.34	5.77	3.85	0.00	2.75	1.37	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.95	6.11	5.79	0.64	2.25	0.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	38.65	5.48	7.00	0.30	3.04	1.52	1.22	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	39.33	6.58	5.46	0.14	2.24	1.68	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	21.69	8.18	4.27	0.36	1.78	1.07	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	45.57	5.82	4.36	0.48	5.82	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	50.26	8.71	3.58	0.00	2.96	1.09	0.93	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	29.72	7.52	4.30	0.00	1.79	0.00	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	57.82	2.94	7.19	0.00	2.29	0.98	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	47.79	6.83	5.18	0.24	2.35	1.41	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	66.83	11.51	4.70	0.87	2.10	0.25	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	44.31	5.63	4.10	0.00	2.31	0.51	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	64.45	6.56	4.77	0.60	3.28	1.49	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	108.77	11.33	6.80	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	126.58	16.88	7.67	0.00	4.60	1.53	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	86.10	18.56	8.16	0.74	1.48	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	88.01	11.00	6.77	0.00	2.96	2.54	0.85	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	110.42	10.55	6.33	0.00	2.81	5.63	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	87.79	10.27	5.60	0.00	3.74	2.80	4.67	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	66.98	9.79	6.18	0.00	1.55	1.55	0.52	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	122.51	13.08	13.08	0.00	2.38	0.00	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	85.95	13.57	8.60	0.90	2.49	2.94	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	64.56	12.51	6.69	0.29	2.04	1.45	0.58	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	79.23	12.60	4.95	0.00	1.80	0.45	1.35	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	100.53	19.24	10.43	0.27	4.74	2.85	1.90	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	95.52	13.87	8.73	1.03	5.65	2.05	1.54	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	92.10	16.58	4.23	0.35	2.82	1.76	2.12	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	69.30	9.99	6.00	0.00	0.67	2.67	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	92.20	13.75	12.23	0.00	5.09	2.04	1.53	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	92.05	16.54	6.40	0.00	4.00	1.60	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	76.33	13.04	4.91	0.38	3.21	1.70	1.32	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	76.70	14.11	8.59	0.00	7.36	1.23	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	128.02	20.39	7.34	0.00	4.89	2.45	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	76.22	12.91	6.25	0.00	2.50	2.08	1.67	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	62.50	12.33	3.36	0.28	1.40	1.40	1.96	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	118.49	16.49	10.30	0.00	2.06	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	84.19	15.39	7.55	0.29	2.61	2.61	2.61	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	58.29	17.04	6.28	0.00	3.89	1.79	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	81.88	12.72	6.64	0.55	1.66	1.66	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	88.37	21.92	7.78	0.00	5.66	3.89	2.47	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	78.18	14.01	9.59	0.37	3.69	2.58	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	88.65	10.36	9.21	0.00	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	88.65	18.80	9.98	0.38	3.45	2.30	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	74.16	19.81	6.79	0.00	3.96	1.13	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	99.28	27.08	8.20	0.00	2.46	4.92	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	89.02	13.56	8.13	0.90	3.62	1.81	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	85.46	12.93	7.18	0.72	3.59	0.72	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	115.02	20.91	4.48	0.00	2.99	1.49	2.99	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	121.51	19.32	4.83	0.00	2.60	1.49	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	69.35	9.91	4.74	0.00	2.15	2.15	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	119.88	22.26	5.99	0.00	5.14	0.86	5.14	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	92.96	17.99	8.66	1.00	3.00	2.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	91.70	13.88	8.45	0.60	6.03	1.81	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	134.38	22.04	8.53	1.42	2.84	5.69	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	99.68	17.19	7.56	0.34	3.09	1.72	1.72	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	87.49	10.20	5.90	0.54	2.15	1.07	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	127.27	14.14	4.04	0.67	2.02	2.69	3.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	110.01	16.30	11.85	0.37	2.96	1.48	2.59	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	126.76	11.63	3.49	0.00	1.16	2.33	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	122.70	26.44	7.40	1.06	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	109.24	20.41	7.20	0.40	5.60	0.80	3.20	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	89.41	16.72	7.27	0.00	0.73	0.73	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	141.81	21.46	9.20	1.53	3.83	3.83	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	90.76	19.73	9.87	0.00	2.47	3.95	2.96	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	76.22	17.88	7.53	0.00	6.59	2.82	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	139.28	24.14	11.06	0.00	4.53	6.03	2.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	98.24	14.42	10.36	0.45	4.51	3.60	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	70.57	17.21	5.16	1.72	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	121.13	20.49	9.35	0.45	3.12	2.23	1.34	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	91.50	17.21	8.60	0.00	3.91	2.74	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	77.19	19.79	5.28	0.00	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	103.27	19.20	5.19	0.52	4.67	2.08	2.08	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	117.27	19.25	4.81	0.88	2.63	4.38	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	94.49	17.89	8.39	0.00	2.80	2.80	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	111.74	18.11	10.16	0.00	4.42	2.21	2.21	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	103.37	14.66	6.17	0.39	4.24	2.70	1.93	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	83.04	12.66	9.62	0.00	3.54	1.01	1.01	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	110.06	12.98	4.81	0.00	0.96	3.84	3.36	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	88.26	15.11	5.17	0.40	3.58	3.58	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	79.60	17.01	9.11	1.22	6.08	3.65	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	91.30	11.07	6.92	0.00	2.08	1.38	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	82.08	18.62	6.08	0.38	3.42	1.14	0.76	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	86.76	14.46	8.26	1.03	3.10	1.03	1.55	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	90.09	19.95	7.26	0.00	1.81	1.81	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	80.49	15.53	5.39	0.32	4.12	1.58	1.58	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	75.17	11.19	12.26	0.53	1.60	2.67	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	90.22	14.37	6.90	0.00	4.02	1.15	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	69.42	16.46	5.66	0.51	5.14	4.63	3.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	69.32	9.90	7.07	0.00	7.07	2.83	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	100.45	23.27	10.78	1.13	1.70	2.27	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	91.94	17.47	4.58	0.00	2.08	1.66	2.08	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	80.65	21.14	9.40	0.00	3.92	2.35	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	91.44	17.12	8.35	0.00	2.09	1.25	1.67	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	92.93	18.59	9.29	0.00	2.32	1.39	1.39	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	76.94	14.05	3.35	0.67	4.01	2.68	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	94.63	17.11	10.16	0.00	1.07	2.67	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	82.03	19.40	6.47	0.00	3.64	4.85	1.62	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	110.13	13.77	10.10	0.00	7.34	8.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	164.49	19.56	7.11	0.00	1.78	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	98.59	18.81	9.12	0.00	2.85	1.71	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	88.96	15.34	7.67	0.77	6.90	2.30	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	117.64	16.42	7.11	0.55	3.28	2.19	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	110.47	19.60	8.46	1.34	4.45	0.89	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	114.90	17.68	8.32	0.26	5.72	1.04	1.04	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	139.92	17.24	9.95	0.00	3.32	0.66	1.99	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	135.11	22.86	10.39	2.08	6.24	6.24	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	2.51	16.41	0.00	0.23	0.68	0.00	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	3.30	11.19	0.37	0.18	0.18	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	17.30	14.29	0.52	0.00	1.31	0.79	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.12	3.19	0.53	0.00	0.53	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	2.85	6.65	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	15.84	5.00	1.11	0.42	0.28	0.69	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	29.10	9.17	2.79	1.10	2.69	2.59	1.00	0.20
Mammary Epithelial Cell, donor2	11350-117G9	38.80	5.21	2.90	1.74	2.03	2.32	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	47.14	5.99	2.00	0.00	2.74	2.74	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	4.75	32.54	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	14.82	21.52	1.73	0.65	1.41	1.51	0.43	0.11
Mast cell, donor2	11565-120D8	3.27	16.05	0.00	0.89	0.59	0.00	0.00	0.30
Mast cell, donor3	11566-120D9	0.90	25.21	0.23	1.80	0.00	0.23	0.00	0.00
Mast cell, donor4	11567-120E1	1.95	23.93	0.35	0.18	0.18	0.35	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	8.21	42.58	1.00	2.99	1.11	2.00	1.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	5.25	28.02	0.58	0.58	1.17	2.33	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	5.85	19.04	1.38	1.15	2.64	1.15	0.57	0.00
Mast cell, expanded, donor8	11941-126A6	22.59	36.49	2.01	4.02	1.17	2.51	1.34	0.33
Melanocyte - dark, donor1	11502-119F8	79.80	7.36	6.67	0.90	1.99	1.19	0.99	0.10
Melanocyte - dark, donor2	11582-120F7	20.07	9.69	5.88	0.35	1.73	0.69	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	67.66	8.62	7.03	0.87	3.62	1.96	1.59	0.07
Melanocyte - light, donor1	11274-116H5	45.84	9.64	13.16	2.82	5.17	1.88	1.18	0.24
Melanocyte - light, donor2	11351-117H1	53.23	8.19	21.16	0.00	4.78	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	41.63	6.94	10.41	0.00	5.20	3.47	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	31.97	6.04	3.12	0.83	1.77	1.35	1.67	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	64.01	5.92	12.10	1.08	6.19	1.34	2.42	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	37.23	14.20	6.43	2.14	2.41	1.07	1.87	0.00
Meningeal Cells, donor1	11493-119E8	76.30	14.89	8.19	0.37	4.34	3.97	0.50	0.00
Meningeal Cells, donor2	11573-120E7	42.25	10.12	2.20	0.44	1.76	3.08	0.00	0.00
Meningeal Cells, donor3	11654-122E7	39.94	9.13	3.83	0.24	2.69	2.93	2.28	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.97	11.41	1.71	0.29	0.57	1.71	2.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	1.21	8.75	0.20	0.20	0.00	0.00	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	28.91	17.08	2.63	0.00	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	77.18	7.85	7.85	1.31	3.92	3.92	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	29.42	6.46	7.18	0.72	2.15	0.72	2.15	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.53	5.72	1.91	0.85	0.21	0.21	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.58	8.54	2.01	0.00	0.50	0.50	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	21.98	18.46	10.33	1.10	4.61	1.10	1.10	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	22.65	12.42	10.96	1.46	7.31	3.65	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	27.83	15.96	7.77	0.00	4.30	2.46	2.05	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.94	8.86	2.22	0.28	0.55	0.55	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	25.28	17.47	5.95	0.74	3.72	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	20.92	8.42	3.82	0.13	1.05	0.53	0.79	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.17	14.84	1.19	2.37	0.30	0.89	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	14.01	0.00	4.67	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	34.58	14.09	8.33	0.00	5.76	2.56	1.92	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.42	6.38	2.13	0.35	2.48	1.06	1.42	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.32	7.51	3.13	0.31	1.25	0.94	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	47.17	10.16	4.35	0.00	3.63	0.73	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	3.71	6.63	0.27	0.00	0.27	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	7.01	1.50	0.50	0.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	7.08	10.84	0.72	0.00	0.79	0.29	0.14	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	17.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1.48	16.01	0.00	0.00	0.25	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	2.06	20.61	0.29	0.59	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1.86	11.47	0.00	0.00	0.00	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	2.28	15.14	0.41	0.00	0.62	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	0.00	15.02	0.00	0.00	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	4.65	18.62	0.00	0.47	0.47	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.20	12.60	0.20	0.00	0.20	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	2.38	16.23	0.40	0.00	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.88	6.19	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1.14	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.21	12.31	0.00	0.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	10.13	0.92	0.00	0.00	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.30	13.11	0.00	0.00	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	10.06	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.00	10.79	0.25	0.00	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1.43	9.98	0.48	0.48	0.00	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	5.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.46	8.52	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	0.84	10.94	0.00	0.00	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.61	10.19	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.64	10.51	0.00	0.00	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.44	12.89	0.00	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.00	6.79	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.01	8.62	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	6.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.27	6.79	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1.47	12.35	0.00	0.00	0.00	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	2.18	1.09	0.00	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.44	4.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.00	11.21	0.00	0.00	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	5.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.00	5.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	0.00	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	3.07	0.44	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	2.21	0.00	0.00	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	4.48	0.00	0.00	0.64	0.00	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1.98	3.22	0.25	0.00	0.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.83	6.96	1.39	0.00	0.00	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	0.00	0.00	0.00	0.00	4.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	4.44	5.47	0.00	0.00	0.34	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.07	9.19	0.88	0.00	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.04	8.17	1.78	0.00	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.65	10.94	1.68	0.00	0.00	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.48	6.23	0.00	0.00	0.00	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	6.99	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.24	11.76	0.90	0.00	0.00	0.90	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.43	11.27	0.00	0.00	0.83	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	8.31	0.00	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.95	13.09	0.00	0.00	0.00	0.00	2.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	3.87	12.99	0.41	0.00	0.14	0.28	0.83	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.15	9.33	0.26	0.00	0.26	1.04	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.44	9.44	1.29	0.00	0.43	0.43	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	12.07	0.64	0.00	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.21	7.21	0.80	0.27	0.53	0.53	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	5.39	13.47	0.30	0.30	0.00	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1.70	8.62	0.28	0.14	0.00	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.19	9.56	0.64	0.00	0.32	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	8.18	11.94	0.88	0.00	0.00	0.66	1.33	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.65	9.86	0.38	0.00	0.76	0.76	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.41	13.35	0.00	0.28	0.28	0.00	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	5.65	11.06	0.00	0.25	0.25	0.25	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	6.52	0.00	0.00	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	2.65	10.00	0.29	0.00	0.00	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	2.59	13.84	0.58	0.00	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2.47	18.96	0.41	0.00	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	1.19	6.55	0.00	0.00	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	7.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	7.13	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1.31	18.40	0.00	0.33	0.00	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	15.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.20	13.64	0.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.00	13.97	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.38	18.40	0.00	0.00	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.80	11.72	0.27	0.27	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.45	13.01	0.00	0.00	0.00	0.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.00	16.94	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.73	17.95	0.37	0.00	0.00	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	20.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.07	3.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	9.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.84	8.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	3.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	71.29	4.75	0.00	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.67	6.89	3.88	0.00	1.94	0.43	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	81.00	5.75	3.14	1.05	1.57	1.05	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	27.37	6.67	10.68	0.00	5.34	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	38.40	4.59	10.43	0.42	2.09	1.67	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	109.90	7.61	6.46	1.14	1.14	3.99	3.23	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	157.99	4.79	20.75	0.00	7.98	3.19	6.38	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	8.16	8.84	0.68	3.40	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	154.36	0.00	1.84	0.00	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.88	5.86	14.65	0.00	3.77	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	62.29	5.58	12.55	0.70	2.56	1.16	1.16	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	64.85	5.40	20.27	0.81	3.78	0.27	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	146.96	6.94	19.55	0.21	3.99	2.10	2.94	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	11.13	11.13	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	53.11	3.97	13.90	1.49	3.47	0.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	49.26	5.14	5.68	0.27	0.81	1.35	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	30.83	3.40	12.47	0.23	2.04	0.23	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	61.89	6.21	12.90	0.33	2.12	1.31	1.96	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	105.34	3.65	8.20	1.09	2.00	1.09	1.09	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.75	10.08	11.67	0.00	5.30	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	45.02	4.20	9.00	0.60	0.60	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	89.92	8.86	1.97	1.64	0.33	1.97	2.95	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	44.40	4.55	10.90	0.00	1.30	1.30	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	186.44	5.47	15.17	0.71	1.76	1.94	2.82	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	17.58	7.03	12.66	1.41	2.81	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	62.06	1.38	9.65	0.00	2.76	1.38	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	35.35	7.39	5.14	0.00	1.61	0.32	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	137.96	8.28	2.07	0.00	0.00	3.45	1.72	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	364.10	30.34	0.00	2.53	0.00	17.70	12.64	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	131.00	5.57	13.37	0.22	1.11	0.45	1.34	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	26.67	6.35	8.47	0.00	0.85	0.85	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	112.98	1.90	7.83	0.71	1.66	0.24	2.37	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	26.18	8.16	7.30	0.43	0.43	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	18.06	9.03	9.03	0.00	0.00	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	44.65	13.00	16.66	0.67	1.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	41.48	4.96	11.27	0.45	1.35	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.08	4.76	5.95	0.40	1.19	0.40	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	56.65	3.71	10.22	0.00	1.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.38	4.16	4.16	0.38	0.00	0.38	2.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	19.88	9.78	5.87	0.00	0.00	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	58.83	6.97	15.69	0.87	2.61	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	45.68	4.98	10.40	0.45	0.90	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	3.53	5.29	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	57.18	8.64	10.64	0.00	1.99	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.87	9.42	3.97	0.50	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	8.04	3.83	0.00	0.00	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	36.90	7.86	6.05	1.81	0.00	0.30	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	27.85	6.41	3.98	0.00	0.00	0.88	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	4.07	10.16	0.68	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	255.48	15.33	0.00	0.00	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	11.58	6.71	5.49	0.00	1.83	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.11	5.04	1.26	0.00	1.57	0.00	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	79.30	9.99	8.47	1.51	1.51	0.30	1.21	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	3.16	1.58	0.00	1.58	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	53.28	6.80	0.00	0.00	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	177.03	15.17	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	14.04	6.71	1.49	0.62	1.12	0.00	0.25	0.00
Myoblast, donor2	11322-117D8	28.38	10.93	3.45	0.00	1.34	0.77	0.58	0.19
Myoblast, donor3	11398-118D3	31.78	8.91	6.89	0.50	1.85	0.17	0.50	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	244.15	46.26	3.65	8.32	1.46	7.00	4.23	0.44
Natural Killer Cells, donor1	11230-116C6	84.57	78.42	1.23	5.54	0.00	3.38	4.00	0.92
Natural Killer Cells, donor2	11311-117C6	90.47	64.53	0.90	2.11	0.30	1.81	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	65.71	68.84	0.92	6.99	0.92	2.02	1.66	0.37
Neural stem cells, donor1	11275-116H6	20.32	19.60	9.07	2.90	5.44	1.81	1.81	0.00
Neural stem cells, donor2	11352-117H2	13.48	13.48	1.93	0.00	1.93	0.00	1.93	1.93
Neurons, donor1	11494-119E9	15.93	0.00	4.55	1.14	0.00	0.00	0.00	1.14
Neurons, donor2	11574-120E8	8.59	4.40	4.62	1.10	1.54	1.54	0.22	0.44
Neurons, donor3	11655-122E8	13.15	0.82	0.00	0.00	2.47	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	0.93	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	15.88	0.61	0.00	0.61	0.00	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	29.09	6.53	2.26	1.07	1.42	0.59	0.24	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	36.47	9.77	4.56	0.33	3.58	0.65	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	24.87	6.62	6.62	0.00	1.60	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	37.85	6.33	5.37	0.00	1.65	0.41	0.41	0.00
Olfactory epithelial cells, donor2	11934-125I8	19.40	8.83	5.93	0.72	2.32	0.58	0.43	0.00
Olfactory epithelial cells, donor3	11935-125I9	19.98	7.83	4.20	0.45	1.82	0.45	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	17.04	5.06	3.02	0.97	1.66	0.88	0.88	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	11.43	10.23	1.20	0.60	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	13.40	11.91	2.13	0.43	0.43	0.00	0.64	0.00
Osteoblast - differentiated, donor2	11353-117H3	11.43	11.43	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	32.28	6.83	4.34	0.62	1.86	1.24	1.24	0.00
Osteoblast, donor1	11277-116H8	22.48	16.22	8.21	0.59	3.32	0.59	0.39	0.39
Osteoblast, donor2	11354-117H4	36.52	18.96	2.81	1.40	3.51	2.11	0.70	0.00
Osteoblast, donor3	11426-118G4	18.48	20.79	3.91	0.89	2.31	1.42	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	44.48	8.00	5.39	1.26	1.35	1.01	0.59	0.08
Pericytes, donor1	11491-119E6	71.88	20.58	11.24	1.22	3.00	0.78	0.33	0.11
Pericytes, donor2	11571-120E5	54.78	13.81	19.01	0.23	2.72	0.91	0.68	0.00
Pericytes, donor3	11652-122E5	16.07	8.14	2.44	0.20	1.83	0.61	0.20	0.41
Perineurial Cells, donor1	11499-119F5	73.92	7.01	6.44	0.34	1.47	1.92	0.90	0.00
Perineurial Cells, donor2	11579-120F4	26.13	12.79	3.22	0.46	2.02	0.64	0.74	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	90.20	66.94	0.64	4.14	0.96	0.96	1.27	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	32.08	19.83	0.00	1.22	0.24	0.73	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	100.81	41.15	1.16	2.98	0.91	2.33	1.55	0.00
Placental Epithelial Cells, donor1	11278-116H9	38.74	4.78	4.78	0.48	3.35	0.48	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	14.42	13.31	7.76	0.00	4.44	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	84.22	9.23	9.23	0.59	6.28	2.16	1.77	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	1.27	6.01	0.32	0.00	0.00	0.32	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	1.13	5.25	0.19	0.00	0.00	0.00	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	3.65	22.45	0.65	0.52	0.39	0.39	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	2.25	10.58	0.23	0.00	0.23	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	4.05	6.39	0.11	0.21	0.21	0.11	0.32	0.00
Preadipocyte - omental, donor2	11329-117E6	10.91	4.36	0.87	0.00	1.31	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	1.15	9.60	0.29	0.29	0.14	0.00	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	0.98	4.92	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	12.90	18.73	2.46	0.31	3.07	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	20.72	17.53	2.30	0.18	1.77	1.95	1.77	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	10.73	18.05	1.36	0.17	1.19	0.68	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	56.91	16.21	4.47	0.93	3.07	2.05	1.21	0.09
Preadipocyte - visceral, donor2	11357-117H7	27.15	22.09	2.30	0.46	0.92	1.84	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	26.54	11.08	4.08	0.00	1.46	0.63	0.21	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	10.86	1.36	0.91	0.30	0.91	0.75	0.60	0.15
Prostate Epithelial Cells, donor2	11331-117E8	1.22	2.44	0.27	0.41	0.00	0.41	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	4.90	1.59	0.24	0.86	0.18	0.12	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	70.50	5.35	7.40	0.23	2.05	1.59	1.37	0.00
Prostate Stromal Cells, donor2	11332-117E9	36.76	10.40	7.17	0.00	3.59	2.15	0.72	0.00
Prostate Stromal Cells, donor3	11405-118E1	22.73	7.09	4.59	0.31	1.67	0.52	0.31	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	11.68	10.95	8.03	1.09	4.01	1.46	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	4.09	4.23	0.55	0.14	0.97	0.90	0.14	0.00
Renal Epithelial Cells, donor1	11517-119H5	23.33	9.64	13.70	0.00	7.10	2.54	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	10.67	14.94	7.11	0.00	4.98	2.85	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	5.40	7.73	1.48	0.00	0.95	0.74	0.32	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	37.45	11.57	3.40	0.00	4.77	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	24.26	11.72	2.70	0.13	2.16	1.35	1.75	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.20	14.65	5.77	0.89	3.33	2.66	2.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	10.65	7.32	2.66	0.00	2.66	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	20.03	9.02	4.40	0.44	0.88	0.88	0.88	0.00
Renal Mesangial Cells, donor2	11598-120H5	10.66	12.54	8.15	0.00	0.00	0.63	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	12.76	7.21	4.44	0.28	1.39	1.11	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	16.11	12.35	4.29	0.81	2.68	2.68	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.75	10.96	0.84	0.00	1.27	1.27	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.73	11.38	6.94	0.19	3.47	1.35	0.96	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	24.63	4.41	4.15	0.00	2.33	1.81	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	12.79	6.54	1.71	0.28	1.14	1.71	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	24.70	8.23	8.23	0.00	2.06	1.03	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	4.27	2.76	1.25	0.00	1.25	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	26.73	9.76	1.20	1.47	0.53	0.00	0.53	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	11.61	6.25	2.68	0.00	1.79	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.41	15.96	1.65	2.75	1.65	1.65	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.72	6.38	1.74	2.90	1.74	0.58	4.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	35.89	8.71	3.25	0.26	1.95	2.47	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	25.42	9.14	4.67	0.79	4.17	1.59	1.89	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	23.98	11.27	3.90	0.67	2.79	1.78	1.78	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	28.90	10.17	2.98	0.74	1.49	1.49	1.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	26.81	9.32	5.01	0.12	3.15	2.56	1.98	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	30.05	11.09	3.00	0.92	2.31	1.16	1.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	31.49	11.09	4.38	0.82	1.51	2.33	1.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.72	8.77	4.39	0.61	2.72	1.36	1.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	25.62	6.81	3.76	1.43	3.76	1.61	1.25	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	31.70	8.03	3.44	0.43	2.87	1.72	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.57	8.05	4.61	0.75	3.54	2.58	1.50	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	25.67	7.52	3.10	0.22	1.77	2.21	1.55	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	28.49	10.90	4.01	0.76	3.06	3.25	1.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	27.48	8.57	3.63	0.56	3.17	1.77	2.05	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	30.25	8.27	2.25	1.88	2.07	1.50	1.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	48.17	9.02	4.78	0.53	2.92	1.86	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	28.72	8.27	3.21	1.17	2.82	3.02	1.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	26.54	9.36	2.67	0.38	3.63	1.34	1.15	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	36.52	10.15	2.78	0.43	2.99	2.14	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	24.67	5.89	5.33	0.00	3.36	1.12	3.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.75	9.40	3.25	0.85	2.56	2.73	1.88	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	36.10	8.75	5.47	0.18	2.37	1.46	1.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.86	8.95	3.80	0.37	2.45	2.70	1.23	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	26.33	9.54	2.42	0.40	2.96	1.07	1.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	22.88	8.96	3.07	0.47	2.83	1.89	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	25.00	7.14	2.38	0.00	1.79	2.38	2.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	23.38	8.42	3.27	0.94	2.81	1.64	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	20.11	9.33	1.24	0.41	3.32	1.24	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	25.22	5.75	3.10	0.22	3.76	2.43	1.55	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	21.72	10.44	2.92	0.63	1.25	1.25	1.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.20	10.77	3.23	0.40	2.02	3.23	1.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	30.82	7.49	3.58	0.17	3.58	2.38	2.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	26.80	10.22	5.59	0.19	1.74	4.05	2.12	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	27.85	11.35	4.64	0.34	2.75	1.03	1.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.08	10.97	7.00	0.00	5.35	3.57	2.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	29.06	10.51	3.78	0.49	2.46	2.46	2.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	32.55	11.25	3.58	1.36	2.39	1.87	1.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.08	11.39	2.96	0.74	2.52	2.81	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	22.39	12.53	2.13	0.27	3.47	2.67	2.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	25.99	8.85	3.04	0.41	2.07	1.24	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	19.05	8.57	2.38	1.19	2.38	1.90	1.67	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.61	15.52	2.82	1.41	3.83	4.64	1.81	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	25.90	10.36	2.92	0.28	2.35	2.17	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	24.11	9.43	3.84	1.40	2.10	2.79	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	12.39	12.69	1.51	0.60	1.81	0.30	1.81	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	20.93	14.81	2.33	0.37	3.67	1.71	0.98	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	27.36	23.00	6.11	3.06	3.49	2.91	2.18	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	19.47	12.78	4.26	3.04	3.04	1.22	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.99	10.85	2.71	0.30	0.90	2.41	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.30	8.14	5.43	1.36	3.39	1.13	1.81	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	23.66	13.48	2.70	3.00	3.00	2.70	3.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	16.88	13.46	2.72	0.59	1.30	1.18	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	19.42	8.75	4.48	0.85	5.34	0.85	1.28	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.63	12.02	4.21	3.00	3.00	2.40	2.40	0.60
Schwann Cells, donor1	11498-119F4	65.07	12.04	15.42	0.00	8.65	3.01	1.32	0.00
Schwann Cells, donor2	11578-120F3	20.41	6.80	17.01	0.00	3.40	3.40	3.40	0.00
Schwann Cells, donor3	11659-122F3	28.70	10.73	9.42	1.10	3.07	2.19	0.88	0.22
Sebocyte, donor1	11220-116B5	43.27	9.86	3.29	1.10	1.10	1.10	1.10	0.00
Sebocyte, donor2	11301-117B5	56.98	4.60	1.38	0.00	0.92	3.22	0.92	0.00
Sebocyte, donor3	11378-118B1	24.73	7.01	3.50	0.82	0.82	0.21	1.03	0.00
Sertoli Cells, donor1	11255-116F4	24.85	1.66	6.63	0.00	3.31	0.00	3.31	0.00
Sertoli Cells, donor2	11333-117F1	8.47	5.65	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	30.00	12.23	13.28	1.67	2.02	0.79	0.44	0.00
Skeletal Muscle Cells, donor2	11358-117H8	31.81	10.12	5.06	0.00	2.17	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	107.85	13.38	18.39	0.84	10.87	3.34	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	81.06	7.85	5.18	0.47	2.36	2.36	1.41	0.00
Skeletal Muscle Cells, donor5	11455-119A6	78.93	9.22	8.18	0.30	3.57	2.08	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	33.55	12.31	12.00	0.31	5.23	2.31	1.39	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	39.69	17.01	5.42	2.90	2.77	1.01	2.52	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	70.92	12.70	11.42	2.14	5.14	2.14	2.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	47.32	16.87	7.34	0.10	3.08	2.78	1.19	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	23.84	16.34	9.01	0.51	1.77	0.42	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	62.97	8.69	13.75	0.72	0.72	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	22.43	14.45	9.08	0.55	1.79	0.69	0.41	0.00
Skin - palm, donor1	10286-104F7	34.92	0.00	0.00	0.00	0.00	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	2.31	2.31	0.29	0.43	0.14	0.29	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	10.63	14.72	0.00	0.82	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.57	3.25	1.56	0.52	0.39	0.39	0.52	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	8.34	4.73	1.11	1.39	0.28	0.14	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	13.36	3.94	0.70	0.42	0.14	0.42	0.56	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	38.48	20.51	1.27	1.90	1.90	2.96	1.48	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	35.53	4.80	1.05	0.82	0.60	0.52	0.67	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	14.50	7.71	0.62	0.00	0.62	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.23	12.90	1.33	0.44	0.44	0.89	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.80	7.64	5.29	0.00	0.59	0.59	2.94	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	40.88	8.62	5.08	0.00	1.33	1.10	2.43	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.99	8.27	1.58	0.39	0.39	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.08	10.82	3.86	0.00	1.55	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	31.02	23.02	9.01	2.00	1.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	8.12	5.32	1.06	0.27	0.67	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	24.38	7.76	1.33	0.22	0.66	0.44	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	4.48	1.79	0.64	0.00	0.51	0.13	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.05	8.47	2.93	0.65	1.95	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	12.11	11.81	2.95	0.59	2.66	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.52	6.41	2.14	0.00	0.57	0.00	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	20.82	11.71	9.60	0.49	1.95	1.14	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	61.19	8.52	13.40	2.44	1.83	0.91	1.52	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	54.81	12.63	5.56	0.25	2.27	0.76	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00	0.00	0.00	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.64	8.58	3.34	0.00	0.00	0.95	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	40.70	4.72	7.23	0.44	1.92	0.74	0.59	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.86	6.46	6.46	0.22	1.72	0.65	1.08	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	34.64	8.19	7.66	0.52	1.89	1.36	0.73	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.62	9.28	1.24	0.15	0.77	0.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	12.93	5.39	2.16	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.25	7.47	1.79	0.30	0.30	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	45.75	15.36	17.75	1.02	5.12	1.37	1.37	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	63.06	10.21	10.05	1.18	3.38	1.02	0.63	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	4.33	12.98	1.31	0.30	0.91	0.40	0.60	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	27.76	6.83	3.41	0.23	0.68	1.59	2.28	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	1.81	1.21	0.00	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	142.79	9.80	7.95	0.00	4.24	3.44	2.38	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	24.10	6.52	6.66	0.27	1.86	1.20	0.67	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	32.18	8.26	4.38	0.38	1.00	0.63	0.75	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.42	3.04	3.30	0.76	1.27	0.25	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	46.44	16.43	6.33	0.75	5.73	0.75	1.06	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.75	10.50	4.50	0.00	2.25	0.75	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	1.29	2.58	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	27.44	15.81	6.05	2.79	0.93	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	4.04	1.01	0.00	0.50	1.01	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	24.13	3.13	1.88	0.00	0.94	0.00	1.25	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	13.86	10.03	6.49	0.59	1.18	0.59	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	44.90	14.00	10.75	0.42	5.33	2.00	1.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	45.31	14.01	18.69	0.00	6.07	0.47	4.20	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.47	4.61	0.72	0.29	0.29	0.14	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	25.24	7.14	2.04	0.25	2.04	0.00	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	22.94	5.26	4.51	0.00	1.50	0.56	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	31.72	7.55	4.05	0.14	1.54	1.82	0.98	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	3.02	4.19	0.42	0.00	0.34	0.08	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	5.71	1.90	0.00	0.95	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.85	4.40	0.49	0.24	0.24	0.24	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	2.43	4.42	0.00	0.00	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.07	7.90	4.10	0.59	1.76	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	97.76	4.08	8.94	0.97	1.94	0.39	1.75	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	34.11	3.17	2.64	0.26	0.00	0.26	1.32	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	16.74	11.16	6.70	2.23	1.12	1.86	1.86	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	39.53	6.47	8.98	0.00	1.80	0.36	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.26	5.96	1.14	0.57	1.42	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	70.50	7.09	8.27	0.79	1.58	1.18	1.58	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	20.06	5.84	2.79	0.76	0.25	0.00	1.02	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	23.96	8.39	5.99	2.00	2.40	1.60	1.60	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	50.58	5.43	6.27	0.42	1.67	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	121.01	7.79	6.42	1.83	0.92	2.75	1.83	0.00
Synoviocyte, donor1	11291-117A4	4.21	7.74	0.50	0.17	0.50	0.17	0.34	0.00
Synoviocyte, donor2	11368-117I9	18.44	7.04	0.34	0.67	0.50	0.50	0.84	0.00
Synoviocyte, donor3	11440-118H9	25.02	5.59	2.46	0.67	0.22	0.22	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	60.75	23.23	22.51	1.43	7.86	3.57	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	17.84	3.96	0.00	0.00	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	87.29	15.05	24.31	0.69	6.02	2.55	2.08	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	22.01	3.66	2.08	0.43	2.08	1.43	0.43	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	20.49	5.03	3.09	0.39	1.93	1.55	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	22.91	1.72	0.57	0.00	2.29	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	27.31	10.09	1.35	2.46	0.49	0.25	0.49	0.62
Urethra, donor2	10319-105A4	3.60	17.98	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.91	4.52	0.53	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	14.02	2.80	2.00	0.40	0.40	0.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	7.56	2.52	0.23	0.23	0.00	0.00	0.69	0.00
Urothelial cells, donor0	11216-116B1	1.11	3.34	0.00	0.22	0.22	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	46.27	44.49	0.00	0.89	0.00	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	44.32	42.89	1.43	0.00	2.86	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	39.70	33.54	0.68	1.37	0.00	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	65.42	43.04	0.69	3.10	1.03	1.03	1.38	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	53.45	29.05	0.00	2.91	0.00	1.16	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	51.02	43.73	2.08	0.00	0.00	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	52.31	43.14	0.00	1.84	0.92	0.00	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	34.69	34.69	0.00	0.91	0.91	1.83	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	12.83	0.00	0.74	0.00	1.11	3.58	1.48	0.00
Wilms' tumor cell line:HFWT	10597-108E3	19.36	8.80	1.76	0.00	0.00	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	101.67	3.63	6.98	5.03	4.75	4.47	4.47	0.28
achilles tendon, donor2	10292-104G4	14.47	10.33	2.07	2.07	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	58.64	8.92	1.78	1.78	0.51	2.04	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	40.86	0.00	0.46	1.16	1.86	5.34	3.25	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	106.48	20.77	4.04	5.82	5.70	6.65	2.97	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	99.87	30.48	0.82	8.44	1.63	4.35	3.81	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	14.34	10.12	0.84	0.84	1.12	2.53	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	17.98	11.00	0.21	0.00	0.42	3.17	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	29.40	9.26	1.09	2.99	0.82	2.18	1.09	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	4.85	13.66	0.44	0.00	2.20	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	10.21	3.27	1.23	0.41	2.04	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	20.97	15.14	2.72	1.16	0.78	1.55	1.16	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.25	1.66	0.18	0.00	1.29	2.76	1.10	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	23.40	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	13.48	16.73	0.00	0.00	0.70	2.32	2.32	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	34.17	21.75	1.04	0.00	1.81	3.11	1.55	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	21.92	14.32	1.46	0.00	1.75	4.38	1.46	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	37.18	12.55	0.46	0.46	3.25	9.76	2.32	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	35.37	1.23	0.82	0.82	2.47	5.76	2.47	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	20.26	0.00	0.61	0.00	1.23	0.92	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	15.36	0.00	0.00	0.00	0.00	2.56	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	15.77	0.00	0.30	0.00	0.61	1.21	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	9.87	0.00	0.24	0.00	0.48	2.17	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	34.97	0.22	1.34	0.89	2.23	6.24	1.78	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	38.69	20.01	1.00	0.67	0.67	5.00	3.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	20.44	3.72	1.86	0.00	1.86	9.29	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	11.68	1.51	0.75	0.00	1.88	2.26	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	13.08	1.31	0.00	0.00	0.00	4.80	3.05	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	61.86	3.75	0.00	0.00	3.75	9.37	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	39.80	2.83	0.94	0.71	0.94	5.89	2.12	0.00
adipose tissue, adult, pool1	10010-101C1	5.89	11.48	0.16	1.86	0.00	0.00	0.16	0.31
adipose, donor1	10184-103D4	8.80	0.00	0.00	0.00	0.00	6.45	0.59	0.00
adipose, donor2	10185-103D5	5.27	0.00	3.65	0.00	1.22	3.65	1.22	0.00
adipose, donor3	10186-103D6	9.26	2.45	1.91	0.54	2.18	1.36	3.54	0.00
adipose, donor4	10187-103D7	9.53	1.73	0.87	0.00	4.33	0.87	8.67	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	41.19	35.04	0.00	0.95	1.10	11.68	7.10	0.00
adrenal gland, adult, pool1	10081-102A9	0.00	3.64	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	195.17	18.81	9.74	0.80	8.27	14.54	11.07	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	98.26	6.79	4.29	0.00	3.57	1.79	2.86	0.00
amniotic membrane cells, donor1	12235-129G3	17.16	4.41	0.70	0.00	1.16	0.70	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	31.78	5.41	2.70	0.34	1.35	0.34	2.03	0.00
amniotic membrane cells, donor3	12237-129G5	43.31	4.42	1.47	0.29	0.88	0.88	1.77	0.00
amygdala - adult, donor10196	10167-103B5	5.93	17.79	2.37	4.74	0.00	1.19	1.19	1.19
amygdala, adult, donor10252	10151-102I7	17.84	26.56	1.82	11.35	0.20	0.20	1.42	2.23
amygdala, newborn, donor10223	10360-105E9	13.56	7.10	0.97	8.39	0.32	0.00	0.65	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	36.67	27.63	5.22	1.02	1.91	0.89	0.51	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	25.81	7.28	1.10	0.88	0.00	2.65	1.76	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	115.58	9.02	3.67	0.67	2.67	6.35	3.01	0.00
aorta, adult, pool1	10052-101G7	9.02	15.30	0.78	2.35	0.20	0.20	0.39	0.00
appendix, adult	10189-103D9	18.24	24.84	0.78	1.55	1.16	1.94	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.60	16.51	1.38	3.10	0.69	1.38	2.06	0.69
artery, adult	10190-103E1	2.72	8.15	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	27.38	0.72	7.53	1.74	6.66	2.75	1.45	0.29
b cell line:RPMI1788	10427-106D4	19.93	11.45	0.15	0.00	0.30	2.83	1.04	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.38	6.10	0.28	0.00	0.28	0.00	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	69.26	5.16	7.64	0.50	6.25	2.68	1.19	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	13.22	0.67	0.84	0.50	0.00	0.33	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	26.84	3.36	1.12	0.00	2.80	2.24	0.56	0.00
bladder, adult, pool1	10011-101C2	7.50	10.21	0.87	1.30	0.76	0.33	0.33	0.00
blood, adult, pool1	10053-101G8	59.79	11.07	0.00	2.21	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	42.82	12.85	13.70	0.00	6.85	2.57	2.57	0.00
bone marrow, adult	10192-103E3	4.72	8.77	4.72	1.35	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	3.08	10.25	2.05	9.23	2.05	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	6.68	11.69	2.56	6.24	1.22	0.11	0.33	0.56
brain, fetal, pool1	10085-102B4	0.00	5.34	0.00	2.67	0.00	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	197.89	12.88	4.29	0.33	5.29	1.65	2.64	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.34	5.24	2.25	0.50	2.00	1.75	1.25	0.12
breast, adult, donor1	10080-102A8	55.56	8.21	1.26	1.89	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	133.52	0.00	3.05	1.65	5.34	1.91	0.89	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	98.02	3.40	4.33	3.09	4.95	4.33	1.24	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	34.76	21.87	2.76	1.38	2.07	5.76	5.06	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	84.73	1.94	7.02	2.91	6.29	3.15	1.21	0.48
carcinoid cell line:NCI-H1770	10703-109H1	43.26	0.47	4.23	18.81	1.88	3.76	1.41	2.35
carcinoid cell line:NCI-H727	10735-110B6	148.76	8.86	7.66	9.30	2.52	4.38	1.31	1.20
carcinoid cell line:SK-PN-DW	10719-109I8	62.43	0.00	2.22	2.22	3.17	3.80	3.49	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	69.47	11.18	17.83	8.78	7.99	5.06	2.66	0.53
caudate nucleus - adult, donor10196	10177-103C6	5.76	18.42	1.15	18.42	0.00	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	20.75	34.47	1.84	24.43	0.33	1.84	1.17	4.52
caudate nucleus, adult, donor10258	10379-105H1	2.29	23.69	0.00	33.62	0.00	0.00	0.00	3.06
caudate nucleus, newborn, donor10223	10354-105E3	8.42	8.79	0.37	15.02	0.37	0.73	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	40.79	32.05	0.00	84.48	0.00	14.57	5.83	8.74
cerebellum, adult, donor10252	10166-103B4	95.87	31.17	1.28	99.71	0.64	11.74	11.10	16.01
cerebellum, adult, pool1	10083-102B2	28.29	7.59	1.72	44.15	1.72	3.10	0.34	3.10
cerebellum, newborn, donor10223	10357-105E6	33.21	4.98	3.32	39.85	0.83	2.49	6.64	4.15
cerebral meninges, adult	10188-103D8	4.54	10.34	1.01	5.55	0.25	0.25	0.25	1.26
cerebrospinal fluid, donor2	10294-104G6	4.39	5.12	2.19	2.19	0.73	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	15.96	0.00	1.73	4.03	2.88	1.58	0.58	0.43
cervical cancer cell line:ME-180	10553-107I4	103.74	0.00	2.15	0.66	1.16	2.15	3.15	0.00
cervix, adult, pool1	10013-101C4	13.44	16.17	1.89	6.93	1.15	0.42	0.31	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	48.91	8.92	4.74	3.20	1.39	0.42	0.28	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	3.92	1.31	0.00	2.61	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	9.57	12.30	0.62	0.12	0.99	2.11	0.62	0.00
choriocarcinoma cell line:SCH	10785-110H2	18.61	9.12	0.25	0.00	0.25	1.97	0.99	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	39.37	5.93	0.71	0.47	2.61	0.95	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	6.27	2.28	0.85	0.00	0.57	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	18.69	5.37	2.29	0.40	1.29	0.10	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	10.99	1.65	0.00	0.00	0.00	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	26.25	23.23	2.02	5.05	1.01	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	18.44	7.30	2.31	0.00	1.34	2.88	0.96	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	42.66	9.50	1.48	0.21	3.17	3.38	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	15.92	9.50	0.77	0.00	0.77	6.68	2.31	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	19.11	7.01	0.00	0.00	2.66	8.47	2.18	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.53	8.14	0.00	0.20	1.43	5.29	2.44	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	18.55	11.19	0.29	0.00	0.88	2.94	2.36	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	47.43	18.50	0.52	0.78	1.30	7.04	1.56	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	23.54	20.34	1.60	0.69	1.83	6.63	3.66	0.23
clear cell carcinoma cell line:TEN	10636-108I6	53.79	1.74	0.87	0.17	0.87	3.64	1.91	0.00
colon carcinoma cell line:CACO-2	10513-107D9	18.67	6.41	0.55	0.18	2.38	2.01	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	60.43	7.22	2.66	0.38	4.18	7.98	6.46	0.00
colon, adult, donor1	10082-102B1	26.18	16.66	0.00	3.57	1.19	2.38	1.19	1.19
colon, adult, pool1	10014-101C5	12.81	13.16	0.59	2.35	0.94	0.71	0.47	0.24
colon, fetal, donor1	10070-101I7	35.84	18.54	3.09	1.24	1.24	1.24	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	9.17	4.58	0.00	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	15.30	50.57	0.00	0.00	0.00	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.64	43.47	0.45	0.30	0.45	0.60	0.30	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	18.75	52.60	0.42	0.42	0.14	1.13	0.71	0.28
corpus callosum, adult, pool1	10042-101F6	17.69	21.89	5.42	6.08	1.33	0.55	0.77	1.33
cruciate ligament, donor2	10295-104G7	8.92	8.92	1.62	0.00	0.81	1.62	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	20.87	12.04	3.21	0.00	0.00	0.80	1.61	0.00
diencephalon, adult	10193-103E4	6.00	9.84	1.44	6.96	0.00	0.24	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	43.86	19.06	0.23	0.23	0.00	6.43	1.61	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	64.88	10.00	1.80	1.80	3.08	3.85	3.33	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	165.62	1.69	6.26	0.00	2.89	0.72	0.96	0.00
ductus deferens, adult	10196-103E7	0.50	13.95	0.50	1.00	0.00	0.00	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	15.84	7.20	0.00	2.88	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	15.45	11.77	1.47	7.36	1.47	2.94	0.00	0.00
dura mater, adult, donor1	10041-101F5	71.03	17.67	4.54	2.23	3.30	1.40	1.73	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	42.64	10.66	1.78	0.44	3.11	1.78	3.11	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	51.87	5.30	6.45	0.14	5.59	2.72	1.58	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	74.61	19.12	6.78	1.23	2.47	3.08	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	63.27	18.77	2.72	0.61	2.72	1.21	2.72	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	86.14	21.30	0.93	0.00	1.85	1.85	2.78	0.31
embryonic pancreas cell line:2C6	10603-108E9	169.44	19.70	3.94	0.00	0.00	3.94	5.25	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	28.49	1.68	4.36	0.00	2.35	0.67	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	26.64	18.49	3.26	1.27	2.36	2.17	1.81	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	20.26	5.63	0.64	0.64	0.48	2.41	1.45	0.00
epidermoid carcinoma cell line:A431	10426-106D3	116.83	4.78	6.34	0.56	3.45	2.45	3.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	190.60	1.43	7.26	0.22	5.72	2.86	3.08	0.11
epididymis, adult	10197-103E8	2.93	23.65	0.42	1.67	0.00	0.21	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	73.98	17.92	6.39	5.32	5.68	1.42	2.48	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	75.11	6.29	6.69	0.00	2.36	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	94.36	0.00	1.18	2.36	1.05	3.67	3.67	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	93.99	0.00	1.08	3.35	1.18	2.85	2.76	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	83.24	0.00	1.12	2.69	1.34	3.70	2.80	0.90
esophagus, adult, pool1	10015-101C6	16.25	8.18	0.53	2.12	1.17	1.06	0.32	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	515.60	3.51	11.65	1.63	3.26	2.00	5.39	0.13
eye - muscle inferior rectus, donor1	10272-104E2	7.24	14.49	2.41	2.41	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	4.46	5.95	0.00	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	0.00	13.76	0.00	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	4.37	1.46	1.46	1.46	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	8.14	6.86	1.27	2.29	0.25	0.51	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	25.52	10.26	0.90	0.00	1.03	1.41	0.90	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	118.95	11.63	5.94	0.95	4.99	4.75	4.75	0.00
frontal lobe, adult, pool1	10040-101F4	5.72	25.99	1.78	12.85	0.66	0.56	0.66	2.63
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	70.86	6.31	4.20	0.30	2.70	4.80	3.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	30.91	11.61	6.86	9.88	2.19	1.10	0.91	0.27
gall bladder, adult	10198-103E9	6.52	16.66	2.17	0.72	0.48	0.72	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	106.30	95.02	1.07	9.13	4.29	2.15	6.44	0.54
gamma delta positive T cells, donor2	11938-126A3	106.07	38.84	2.61	8.22	1.49	2.24	1.87	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	102.23	1.69	1.69	0.84	1.48	2.11	1.90	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.63	4.64	0.58	0.39	0.39	1.16	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	17.05	34.43	0.98	0.00	1.15	2.62	1.64	0.00
gastric cancer cell line:GSS	10560-108A2	32.03	47.59	1.83	0.92	2.75	3.66	2.75	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	68.77	10.05	7.08	22.85	2.51	2.06	2.06	0.91
giant cell carcinoma cell line:LU65	10487-107B1	1.03	0.00	0.11	1.03	0.00	0.11	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	75.58	12.88	6.16	2.38	3.92	0.28	0.84	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	24.19	2.49	0.25	0.00	1.00	0.00	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	51.83	6.44	5.70	0.42	3.59	1.69	2.22	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	47.89	5.20	7.30	0.84	4.77	2.53	2.11	0.00
glioblastoma cell line:T98G	10485-107A8	102.76	7.62	26.05	3.97	12.25	1.99	2.43	0.55
glioma cell line:GI-1	10413-106B8	28.41	18.16	5.56	2.64	1.76	0.59	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	20.41	19.68	4.37	12.39	1.46	2.19	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	67.13	26.85	6.83	12.45	0.24	0.24	0.49	3.17
globus pallidus, adult, donor10258	10367-105F7	6.85	6.85	4.11	10.95	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	4.26	7.99	1.60	11.72	0.53	0.00	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	36.71	9.79	2.45	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45	0.00	0.00	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.32	6.72	1.92	0.64	2.56	1.92	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	13.31	5.97	0.46	0.46	0.46	3.21	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	13.72	8.23	1.37	1.37	0.91	2.29	1.83	0.00
hIPS +CCl2, biol_rep3	14385-156C2	11.59	7.73	0.00	0.64	1.93	3.86	0.00	0.00
hIPS, biol_rep1	14380-156B6	4.31	7.19	0.00	0.00	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	7.54	5.49	0.00	0.00	0.69	2.06	1.37	0.00
hIPS, biol_rep3	14382-156B8	4.41	9.93	1.10	14.35	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	15.23	32.47	0.00	0.86	0.29	2.30	0.86	0.57
heart - mitral valve, adult	10205-103F7	4.48	10.76	0.30	1.49	0.30	0.60	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	7.84	8.37	0.00	1.05	0.00	0.00	0.26	0.52
heart - tricuspid valve, adult	10207-103F9	3.33	14.99	0.00	0.00	0.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	12.24	11.63	0.00	0.41	0.41	0.82	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	1.70	8.52	0.43	1.28	0.85	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	2.53	4.37	0.46	0.23	0.46	0.23	0.00	0.23
heart, fetal, pool1	10046-101G1	13.45	13.96	2.98	0.92	1.44	0.72	0.62	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	2.78	8.64	0.62	0.00	0.31	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	67.78	5.95	7.14	0.00	5.95	10.70	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	87.07	1.66	1.66	0.55	2.54	7.29	4.53	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	82.53	2.67	1.34	0.61	2.55	7.89	4.01	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	91.66	3.13	1.21	1.01	1.82	7.28	4.85	0.51
hepatoma cell line:Li-7	10484-107A7	45.15	0.89	2.22	5.00	0.67	0.78	0.89	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	32.36	4.12	1.91	0.80	1.91	3.02	1.01	0.00
hippocampus - adult, donor10196	10169-103B7	6.62	8.52	0.95	8.52	0.00	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	27.55	28.98	2.25	9.80	0.41	0.41	0.61	2.45
hippocampus, adult, donor10258	10374-105G5	3.98	11.45	1.49	12.45	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	9.52	4.93	1.06	7.75	0.00	0.00	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6.71	10.38	0.00	0.00	0.00	2.44	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	6.68	7.46	0.59	0.39	0.59	2.16	0.98	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	5.33	9.39	0.76	0.25	0.51	1.27	1.02	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.64	0.00	1.13	0.00	1.13	3.95	3.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4.39	1.03	2.07	0.00	1.29	3.61	3.10	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.93	0.00	0.38	0.00	1.90	3.42	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	4.38	2.04	1.17	0.58	0.88	1.17	1.46	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	3.88	1.51	0.43	0.43	2.37	2.15	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	5.00	1.25	0.83	0.42	2.09	0.42	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	6.63	3.08	3.32	0.71	1.18	2.60	0.95	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	11.25	4.18	5.30	0.00	3.38	2.73	0.80	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	8.75	2.69	4.04	2.02	0.67	1.35	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	7.35	7.20	0.16	0.63	0.16	1.72	0.94	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	3.44	4.42	0.00	0.98	0.00	3.93	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.98	7.85	0.00	0.87	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	5.92	0.57	1.15	0.00	1.91	1.72	0.76	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	6.11	0.44	0.44	0.00	1.31	2.18	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	6.00	0.50	0.50	0.00	1.00	2.50	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	4.33	0.38	3.20	0.19	3.58	1.13	1.51	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5.00	0.00	2.73	0.45	2.27	0.91	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4.70	0.94	2.51	0.00	3.13	1.57	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7.35	1.63	3.92	0.82	1.31	1.96	0.65	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.42	1.16	2.90	0.87	0.87	1.74	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	8.37	2.69	6.88	0.60	2.39	1.49	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	15.33	5.36	1.11	0.37	0.74	1.48	0.55	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	11.98	5.99	0.00	0.00	0.57	3.14	1.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	11.84	6.94	0.41	0.00	0.41	1.22	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.15	1.41	0.70	0.00	3.17	2.46	1.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.33	1.27	1.27	0.00	1.27	3.48	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.36	0.00	0.30	0.00	0.30	1.21	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	6.21	1.03	2.59	1.03	3.10	1.55	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	10.63	0.66	3.98	0.00	2.66	1.99	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.18	2.31	1.80	1.03	1.28	0.51	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	11.25	3.32	3.58	0.51	1.53	1.79	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	17.42	1.51	3.79	1.51	2.27	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.07	3.70	3.36	0.00	1.01	3.02	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.28	4.83	1.21	0.00	1.21	2.66	0.97	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	9.36	8.02	0.00	0.45	0.45	4.90	2.23	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	12.20	4.88	0.49	1.95	0.98	1.46	2.44	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	4.89	0.61	1.83	0.00	1.22	3.36	1.53	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	3.25	0.00	0.00	0.00	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	5.63	0.33	0.00	0.00	0.66	1.65	1.65	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	8.21	0.00	2.74	0.00	0.55	1.09	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5.79	0.36	1.45	0.36	0.36	2.17	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.83	0.71	1.07	0.00	2.14	1.07	0.71	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	0.00	1.19	0.00	4.77	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.49	1.49	2.30	0.54	1.63	2.17	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	11.05	0.81	3.23	1.08	1.89	2.96	0.81	0.27
immature langerhans cells, donor1	11904-125F5	1.21	1.45	0.00	0.24	0.00	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	11.09	1.58	0.00	0.00	0.00	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	6.44	25.74	1.70	16.75	0.38	0.57	0.47	3.50
keratoacanthoma cell line:HKA-1	10791-110H8	61.45	0.00	2.28	6.83	2.28	1.63	0.33	0.98
kidney, adult, pool1	10017-101C8	16.52	16.02	1.60	1.60	0.70	0.20	0.80	0.30
kidney, fetal, pool1	10045-101F9	14.29	10.75	1.77	1.98	0.64	0.78	0.28	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	4.83	12.07	0.57	0.57	1.14	0.71	0.57	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.27	7.05	0.41	1.38	0.55	0.41	0.41	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	44.96	0.00	4.77	0.00	0.92	0.55	1.28	0.18
left atrium, adult, donor1	10079-102A7	14.17	3.27	1.63	0.54	0.54	1.09	1.63	0.00
left ventricle, adult, donor1	10078-102A6	2.02	4.55	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	26.27	7.66	1.92	0.00	3.01	2.74	1.64	0.00
leiomyoma cell line:10964C	10569-108B2	16.88	2.51	1.80	0.36	1.08	0.00	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	3.26	5.43	1.09	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	12.14	5.34	0.97	0.24	0.49	0.73	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	29.28	28.23	11.50	1.05	4.18	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	36.01	12.51	1.18	0.24	1.89	3.19	1.18	0.00
liposarcoma cell line:KMLS-1	10782-110G8	9.84	27.96	2.34	0.47	0.62	0.31	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	142.43	18.52	28.39	6.58	12.18	2.44	3.05	0.37
liver, adult, pool1	10018-101C9	15.07	8.10	0.49	0.00	0.16	0.00	0.32	0.16
liver, fetal, pool1	10086-102B5	9.41	3.76	0.00	0.00	0.00	1.88	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	9.19	9.19	3.06	8.90	0.44	0.58	0.44	1.60
locus coeruleus, adult, donor10252	10165-103B3	22.88	18.64	1.29	9.04	0.55	0.55	0.37	2.40
locus coeruleus, adult, donor10258	10375-105G6	4.80	8.46	1.13	12.98	0.56	0.00	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	15.56	17.67	0.00	18.09	0.42	0.42	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	67.81	11.35	6.09	1.80	3.46	0.97	1.11	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	22.75	3.45	4.83	1.38	4.83	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	8.57	3.82	2.50	0.13	2.11	0.79	0.53	0.00
lung, adult, pool1	10019-101D1	54.69	13.70	2.13	2.48	1.54	0.12	0.95	0.24
lung, fetal, donor1	10068-101I5	148.41	25.97	3.71	3.71	0.29	1.43	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	84.31	10.54	6.42	3.21	0.92	0.46	1.83	0.46
lymph node, adult, donor1	10077-102A5	34.08	9.47	0.95	0.00	1.89	0.00	2.37	0.00
lymphangiectasia cell line:DS-1	10727-110A7	23.67	8.99	0.88	0.00	0.44	1.32	0.88	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	27.77	14.64	0.60	1.81	0.15	2.57	0.75	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	118.08	5.95	4.25	2.55	0.85	4.25	4.25	0.00
mature adipocyte, donor1	12231-129F8	0.00	4.88	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	0.42	3.53	0.00	0.62	0.00	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	1.19	2.37	0.00	0.47	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	0.53	1.05	0.00	0.26	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	66.71	21.68	2.86	5.24	1.91	3.34	1.91	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	1.13	16.92	0.00	5.64	0.00	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	18.94	24.46	1.10	21.33	0.55	1.10	1.10	5.89
medial frontal gyrus, adult, donor10258	10368-105F8	4.77	8.58	0.00	22.24	0.00	0.00	0.32	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	14.07	9.38	0.00	4.26	0.00	1.28	0.43	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	6.41	12.32	3.54	12.66	0.34	0.84	0.34	2.36
medial temporal gyrus, adult, donor10252	10156-103A3	23.98	26.95	2.97	18.68	0.21	0.42	0.85	4.24
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	3.85	1.93	19.26	0.00	1.93	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	28.71	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	14.72	8.97	0.00	5.03	0.00	1.08	0.36	1.44
medulla oblongata - adult, donor10196	10174-103C3	8.44	6.49	0.00	9.09	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	24.92	22.14	1.24	12.38	0.31	0.93	1.24	0.77
medulla oblongata, adult, pool1	10038-101F2	9.31	16.57	2.04	9.63	0.16	0.24	0.33	1.39
medulla oblongata, newborn, donor10223	10361-105F1	10.76	5.21	1.04	11.46	0.69	0.00	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	78.82	7.09	17.93	7.97	9.74	5.31	5.31	0.22
medulloblastoma cell line:ONS-76	10759-110E3	209.94	8.68	21.28	3.30	13.69	4.89	3.06	0.49
melanoma cell line:COLO 679	10514-107E1	41.54	29.61	7.47	0.43	3.59	1.15	1.29	0.00
melanoma cell line:G-361	10465-106H6	24.97	9.50	6.24	3.26	4.07	1.36	1.09	0.81
meningioma cell line:HKBMM	10691-109F7	35.10	8.50	2.17	0.36	1.45	0.54	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	167.42	8.81	39.65	22.91	7.93	0.88	2.64	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	80.62	11.67	17.11	8.04	9.33	2.59	1.56	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	13.96	16.72	1.38	0.15	0.31	0.92	1.07	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.73	10.54	0.55	0.00	0.18	0.73	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.70	11.59	1.24	0.00	0.41	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.19	8.29	2.11	0.56	0.42	0.14	0.56	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	19.06	10.40	0.96	0.58	0.19	0.77	0.77	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	32.62	7.63	6.25	0.00	3.47	0.69	3.47	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	16.31	4.63	2.57	0.17	0.17	0.51	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	49.69	9.55	1.96	0.00	0.46	0.69	0.81	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.03	7.96	1.19	0.40	0.40	1.06	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	28.49	13.23	1.89	0.41	0.81	0.68	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	11.24	8.68	1.00	0.00	0.43	1.00	0.57	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	2.96	9.55	0.99	0.00	0.00	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.96	6.50	0.97	0.55	0.55	0.28	0.42	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.96	7.33	1.75	0.70	0.70	0.00	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	2.45	6.33	1.02	0.00	0.41	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	3.24	3.59	1.08	0.36	0.36	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.97	6.41	0.31	0.21	0.31	0.10	0.31	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2.74	3.65	0.46	0.00	0.23	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	10.91	2.94	0.84	0.00	0.42	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	7.02	6.43	0.75	0.00	0.45	0.75	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	14.53	8.75	1.58	0.00	0.26	0.79	0.35	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	2.58	8.47	0.37	0.00	0.00	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	1.14	5.72	0.29	0.57	0.29	0.00	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	77.47	8.00	20.63	1.26	6.74	1.26	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.92	5.02	0.91	0.91	0.46	0.91	2.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	17.65	7.16	0.77	0.26	0.77	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.40	7.07	2.62	0.79	0.26	0.52	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.79	9.55	2.16	0.92	0.62	0.92	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	17.89	7.30	1.65	1.18	0.47	0.47	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.91	9.48	1.02	1.02	0.34	0.68	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.15	8.25	1.57	0.39	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	7.41	1.85	0.93	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	19.04	9.81	3.17	0.29	0.58	0.87	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.74	8.92	2.23	0.22	1.34	0.22	0.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.34	7.93	1.44	0.96	0.24	0.24	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	22.00	11.00	5.13	0.73	2.93	2.20	2.20	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	13.09	8.39	1.01	0.00	0.67	1.01	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.97	9.01	1.64	0.41	0.82	0.41	2.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.03	9.02	1.72	0.00	0.00	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	5.47	0.00	2.73	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	0.00	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.07	7.79	0.65	0.97	0.65	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	5.82	2.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.53	10.13	2.13	1.07	0.00	0.00	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	1.64	8.18	1.64	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.11	4.66	2.33	0.39	0.78	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	4.20	2.10	0.00	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	9.93	0.00	0.99	0.00	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	4.77	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	7.12	0.59	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	9.75	1.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.17	6.33	1.27	0.63	0.00	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.79	5.52	1.72	1.03	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	10.33	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.48	9.78	0.00	0.41	0.41	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	8.74	0.79	0.00	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.36	6.48	0.59	0.59	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	3.43	7.79	0.31	0.62	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1.34	2.67	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	4.73	0.00	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	5.14	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.88	8.26	0.00	0.00	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.99	5.44	0.00	0.49	0.00	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	0.00	5.61	0.00	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	0.64	3.18	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	0.81	4.03	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	0.00	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	0.00	5.07	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	0.00	6.68	0.00	0.00	0.61	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	1.65	3.29	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.57	5.75	0.79	1.98	0.00	0.40	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	2.27	5.84	0.00	0.97	0.00	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	3.06	8.15	0.00	2.04	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	65.77	3.87	3.87	0.77	0.00	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	129.22	20.32	3.31	0.94	1.65	2.36	3.31	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	24.33	2.32	2.32	0.23	1.16	0.70	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	106.84	4.27	8.55	0.00	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	124.53	3.60	8.63	0.31	2.98	1.54	2.88	0.00
mesothelioma cell line:Mero-25	10850-111F4	29.96	1.59	3.18	0.23	0.91	0.45	0.68	0.00
mesothelioma cell line:Mero-41	10851-111F5	59.65	5.38	4.89	0.73	3.42	2.93	0.98	0.00
mesothelioma cell line:Mero-48a	10852-111F6	26.35	10.19	2.21	0.66	1.33	1.99	1.11	0.00
mesothelioma cell line:Mero-82	10853-111F7	87.78	2.63	6.31	0.00	2.37	1.31	2.37	0.00
mesothelioma cell line:Mero-83	10854-111F8	50.56	3.57	5.79	0.34	2.55	0.85	1.02	0.00
mesothelioma cell line:Mero-84	10855-111F9	32.10	3.79	4.55	0.25	2.78	0.25	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	35.82	11.80	7.87	0.62	3.11	1.45	0.83	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	43.23	12.26	3.48	1.49	1.99	0.99	0.50	0.00
mesothelioma cell line:NCI-H226	10846-111E9	14.84	0.54	3.44	0.00	0.72	0.18	0.54	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	85.75	6.49	9.22	0.34	6.15	1.37	2.73	0.00
mesothelioma cell line:NCI-H28	10845-111E8	18.58	0.76	2.54	0.00	2.29	1.53	0.76	0.25
mesothelioma cell line:No36	10857-111G2	50.56	5.22	11.42	0.33	3.91	3.91	2.61	0.33
mesothelioma cell line:ONE58	10858-111G3	32.79	4.88	6.50	0.00	1.63	0.27	1.35	0.00
migratory langerhans cells, donor1	11901-125F2	2.49	5.76	0.00	0.38	0.00	0.00	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	6.11	5.74	0.24	0.49	0.37	0.49	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	3.77	9.33	0.18	0.18	0.00	1.08	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	55.83	16.00	8.49	0.98	1.31	2.94	4.90	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	49.17	0.00	2.97	2.97	1.70	1.27	1.06	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	140.29	2.53	13.82	1.38	7.60	1.84	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	12.56	25.31	0.57	0.38	0.95	2.28	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	43.61	0.00	2.77	0.00	3.51	2.96	1.48	0.00
myeloma cell line:PCM6	10474-106I6	31.03	11.66	6.92	1.19	1.78	1.78	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	120.23	19.28	9.64	0.51	4.57	2.03	7.10	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	113.37	12.95	11.38	4.32	2.94	5.30	4.51	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	40.00	1.00	1.78	0.33	0.89	0.33	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	36.40	1.54	1.32	0.66	0.59	0.37	0.37	0.07
nasal epithelial cells, donor2	12227-129F4	18.77	3.31	2.21	1.66	0.55	0.00	2.21	0.00
neuroblastoma cell line:CHP-134	10508-107D4	22.55	3.68	9.66	0.46	7.36	1.15	0.92	0.23
neuroblastoma cell line:NB-1	10539-107G8	86.06	37.98	34.80	2.25	20.21	5.24	3.37	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	160.06	4.43	8.01	3.59	2.95	2.53	2.32	0.42
neuroblastoma cell line:NH-12	10555-107I6	21.62	6.71	8.57	5.96	5.22	2.24	0.93	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	33.21	9.73	0.47	4.03	1.42	1.90	0.71	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	107.86	12.83	1.43	3.96	1.58	4.12	2.85	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	14.09	3.02	0.40	0.20	0.81	0.81	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	125.88	1.27	2.54	2.54	1.91	10.17	1.91	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	35.13	9.58	4.26	0.00	0.80	0.00	1.33	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	40.59	12.85	2.03	0.17	1.18	6.93	1.18	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	51.23	8.81	25.62	13.61	4.00	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	58.35	16.99	7.37	0.96	0.00	1.60	1.60	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	77.52	8.15	11.04	0.00	1.05	1.31	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	10.69	22.97	1.69	17.44	0.56	0.56	0.47	3.47
occipital cortex - adult, donor10196	10172-103C1	8.24	20.60	6.18	22.66	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	38.64	27.10	1.88	25.76	0.54	0.54	1.61	5.90
occipital cortex, newborn, donor10223	10355-105E4	9.10	13.47	0.73	8.37	0.00	0.36	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	10.23	12.33	2.36	13.64	0.00	0.26	0.52	1.57
occipital lobe, fetal, donor1	10073-102A1	4.29	7.29	0.86	6.87	1.29	0.43	0.86	0.43
occipital pole, adult, pool1	10036-101E9	5.05	16.48	1.42	12.61	0.39	0.24	0.39	2.37
olfactory region, adult	10195-103E6	8.60	12.61	1.34	14.33	0.38	0.57	0.38	1.53
optic nerve, donor1	10277-104E7	10.01	6.00	8.00	6.00	2.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	14.92	0.00	0.68	2.73	0.34	0.91	0.57	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	28.03	3.85	2.75	0.96	2.61	0.96	0.69	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	47.07	5.42	5.93	1.69	2.20	2.03	2.54	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	86.98	6.58	3.00	0.35	3.00	3.12	1.16	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	40.27	7.64	7.64	0.00	5.00	1.18	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	57.93	5.61	7.47	0.00	8.41	2.80	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	41.56	7.42	5.73	1.91	3.39	0.42	0.64	0.00
ovary, adult, pool1	10020-101D2	11.79	11.79	2.88	2.88	1.48	0.17	0.70	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	65.26	5.50	6.97	1.28	3.12	2.93	1.47	0.18
pancreas, adult, donor1	10049-101G4	1.88	3.76	0.00	2.82	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	31.31	12.58	0.56	0.28	1.68	0.84	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	100.34	13.12	18.91	1.70	5.96	1.70	3.92	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	17.72	2.15	2.65	0.66	0.50	0.66	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	6.13	16.02	1.19	13.82	0.18	0.46	0.09	1.56
parietal cortex, adult, donor10258	10373-105G4	1.47	8.07	0.00	19.82	0.00	0.73	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	6.58	7.52	1.88	18.81	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	16.25	22.23	1.43	18.81	0.00	0.57	1.43	8.27
parietal lobe, adult, pool1	10034-101E7	4.32	17.71	1.50	14.19	0.26	0.00	0.26	3.08
parietal lobe, fetal, donor1	10072-101I9	36.85	3.88	8.73	7.76	0.97	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	9.35	9.35	0.37	7.85	0.00	0.37	0.00	1.50
parotid gland, adult	10199-103F1	2.47	3.70	0.00	0.00	0.00	0.62	0.00	0.62
penis, adult	10200-103F2	4.83	15.04	0.54	2.15	0.54	0.00	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	222.19	2.23	2.79	2.05	3.16	2.79	1.67	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	68.33	0.73	6.56	2.33	2.19	0.44	0.73	0.15
pineal gland - adult, donor10196	10179-103C8	7.10	14.19	0.65	9.68	0.00	0.00	1.29	0.65
pineal gland, adult, donor10252	10160-103A7	5.92	22.50	1.78	15.99	0.00	0.00	0.00	1.78
pineal gland, adult, donor10258	10377-105G8	3.14	13.17	0.00	18.81	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	12.14	18.21	0.00	21.25	0.00	1.01	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	10.94	38.05	1.56	40.65	0.52	0.52	0.00	5.21
pituitary gland, adult, donor10258	10378-105G9	3.40	17.88	2.55	22.98	0.00	0.00	0.00	2.55
placenta, adult, pool1	10021-101D3	23.11	11.18	0.97	0.86	0.43	0.32	0.65	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	15.49	14.17	0.40	0.79	0.26	5.83	1.99	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	159.53	8.72	13.54	2.96	2.96	1.87	2.33	0.16
pons, adult, pool1	10033-101E6	6.02	12.65	2.32	12.14	0.69	0.34	0.09	2.24
postcentral gyrus, adult, pool1	10032-101E5	4.62	16.74	1.74	13.60	0.44	0.35	0.35	3.49
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	8.37	0.00	0.00	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	119.73	3.93	4.08	1.31	3.64	1.75	2.62	0.15
prostate cancer cell line:PC-3	10439-106E7	96.01	12.34	11.43	6.35	4.72	1.27	2.18	0.54
prostate, adult, pool1	10022-101D4	4.63	14.06	0.73	2.54	0.09	0.00	0.18	0.91
putamen, adult, donor10196	10176-103C5	16.52	25.49	1.89	18.65	0.24	0.71	0.71	5.19
putamen, adult, donor10252	10152-102I8	15.69	23.53	0.00	11.76	0.00	0.00	0.00	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	6.56	12.02	0.00	9.84	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	4.59	13.53	0.97	15.70	0.00	0.24	0.24	2.17
putamen, newborn, donor10223	10365-105F5	6.00	13.49	0.75	11.24	0.00	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	31.13	2.62	1.45	0.29	3.78	1.45	1.16	0.00
rectum, fetal, donor1	10067-101I4	12.52	25.04	9.74	1.39	2.78	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	51.73	4.66	5.94	4.24	2.97	3.39	1.91	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	13.67	4.97	0.00	0.83	0.41	3.31	1.66	0.00
retina, adult, pool1	10030-101E3	6.86	17.89	0.70	4.37	0.30	0.10	0.70	0.89
retinoblastoma cell line:Y79	10475-106I7	15.59	2.60	5.20	9.35	4.42	2.34	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	60.61	8.24	1.97	0.49	2.95	2.58	2.34	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	79.30	2.25	21.09	0.28	11.53	2.25	2.53	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	106.86	6.82	15.16	0.00	1.52	0.76	3.03	0.76
salivary acinar cells, donor1	11771-123I7	14.73	6.96	0.49	1.46	1.46	0.16	0.65	0.00
salivary acinar cells, donor2	11772-123I8	21.62	5.23	2.75	0.83	0.41	0.55	0.83	0.00
salivary acinar cells, donor3	11773-123I9	22.51	3.97	3.31	1.32	1.32	1.99	1.32	0.00
salivary gland, adult, pool1	10093-102C3	2.29	7.44	0.00	1.14	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	17.54	12.98	1.85	0.25	0.93	0.34	0.17	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	16.10	13.52	2.47	1.29	2.00	1.18	0.59	0.00
seminal vesicle, adult	10201-103F3	1.06	17.46	0.00	2.65	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.33	8.99	3.64	0.49	1.46	1.46	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	75.49	11.32	4.03	2.77	2.26	1.51	1.76	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	73.26	12.04	3.01	3.01	3.01	3.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	23.77	5.51	0.54	0.00	0.54	0.67	0.67	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	172.20	0.77	4.09	1.88	2.32	2.87	0.99	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	31.48	4.39	1.16	0.13	1.03	1.68	0.39	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	2.84	0.00	0.00	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	10.31	5.16	1.80	0.60	0.12	0.00	0.36	0.12
skeletal muscle, fetal, donor1	10066-101I3	98.49	7.04	21.11	1.01	6.03	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	0.00	0.00	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	29.04	9.47	1.26	1.89	1.26	0.63	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	290.50	0.00	13.01	7.34	10.34	4.67	2.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	67.45	12.29	22.06	22.38	0.63	6.93	5.04	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	18.70	21.97	0.77	1.35	0.96	4.82	5.20	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	16.48	0.16	1.15	0.33	1.15	1.65	1.98	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	36.51	0.80	12.87	2.57	10.29	8.20	5.63	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	206.15	11.33	11.33	3.27	3.70	1.74	2.40	0.22
small intestine, adult, pool1	10024-101D6	8.96	11.82	0.84	1.67	0.48	0.60	0.24	0.00
small intestine, fetal, donor1	10064-101I1	30.96	13.02	2.70	2.95	1.47	2.21	0.98	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	78.99	4.10	15.90	10.77	4.62	2.56	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	12.15	14.47	0.52	1.55	0.26	0.78	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	43.96	0.00	20.10	6.16	6.97	1.34	0.00	0.54
spinal cord - adult, donor10196	10181-103D1	21.11	10.32	3.90	9.64	1.15	0.46	0.69	1.15
spinal cord, adult, donor10252	10159-103A6	33.91	18.92	2.76	7.10	0.79	0.00	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	5.53	10.38	2.77	14.53	0.69	1.38	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	26.22	25.61	4.88	12.81	2.44	1.22	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	22.50	10.56	0.92	10.10	0.00	0.46	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.81	10.90	1.64	0.30	1.64	0.90	0.30	0.00
spleen, adult, pool1	10025-101D7	12.89	18.50	0.88	2.09	0.88	0.77	0.77	0.33
spleen, fetal, pool1	10044-101F8	28.52	21.14	1.99	2.46	0.79	1.19	1.11	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	17.08	12.01	0.41	0.31	0.31	1.55	0.83	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	53.36	2.85	1.52	2.28	1.52	1.33	2.47	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	17.47	16.07	0.00	1.40	1.05	3.49	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	34.40	4.69	4.30	0.39	3.13	1.95	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	5.40	1.24	1.13	3.38	0.68	0.45	0.34	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	47.87	1.69	2.97	0.85	2.12	1.27	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	60.08	10.58	8.46	0.42	5.92	2.54	1.69	0.42
stomach, fetal, donor1	10062-101H8	22.43	14.95	1.07	0.00	2.14	4.27	0.00	0.00
submaxillary gland, adult	10202-103F4	7.98	13.67	0.00	2.28	0.00	0.57	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	42.16	31.36	3.12	5.19	0.42	0.42	1.04	1.45
substantia nigra, adult, donor10258	10371-105G2	8.79	8.79	1.03	14.48	0.00	0.00	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	16.25	12.72	2.83	9.19	0.71	0.71	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	101.34	10.32	2.29	8.25	5.73	2.29	1.38	1.38
temporal lobe, adult, pool1	10031-101E4	5.85	19.41	2.29	11.53	0.42	0.85	0.17	1.44
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	14.96	4.99	2.14	7.12	0.71	0.71	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.55	6.59	3.08	3.08	0.88	0.44	0.44	0.44
tenocyte, donor1	11763-123H8	84.83	12.57	7.33	2.09	3.14	1.40	3.84	0.00
tenocyte, donor2	11765-123I1	35.86	12.97	1.53	0.00	0.38	0.38	2.29	0.00
tenocyte, donor3	11768-123I4	46.70	11.12	2.22	0.37	0.74	0.37	1.85	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	47.08	6.97	2.04	0.51	3.74	3.23	1.87	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	46.40	8.79	2.62	0.00	5.86	6.01	2.16	0.00
teratocarcinoma cell line:PA-1	10807-111A6	24.33	7.44	2.17	0.46	4.34	2.32	1.24	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	57.13	10.03	4.82	0.51	2.92	2.03	1.27	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	69.58	16.64	6.43	0.38	7.56	5.29	2.27	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	155.52	7.63	4.58	0.11	2.51	1.96	0.87	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	14.01	5.21	0.65	0.00	2.93	1.63	0.65	0.00
testis, adult, pool1	10026-101D8	3.54	9.13	0.86	1.93	0.21	0.21	0.11	0.21
testis, adult, pool2	10096-102C6	4.06	9.47	1.35	0.90	0.90	0.45	0.45	0.45
thalamus - adult, donor10196	10168-103B6	17.66	8.83	6.62	7.73	0.00	0.00	2.21	1.10
thalamus, adult, donor10252	10154-103A1	40.79	29.22	2.81	12.35	1.09	0.63	0.78	2.50
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	10.78	0.00	23.09	0.00	0.00	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	2.96	5.43	1.65	8.40	0.66	0.00	0.16	0.82
thalamus, newborn, donor10223	10366-105F6	6.90	5.18	0.00	10.93	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	10.24	10.74	0.25	1.25	0.25	0.25	0.50	0.50
throat, fetal, donor1	10061-101H7	25.60	24.07	6.09	4.57	2.13	0.91	0.61	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	26.83	6.96	0.00	1.99	0.40	2.98	1.19	0.40
thymus, adult, pool1	10027-101D9	63.82	27.74	1.79	3.18	2.58	3.58	2.68	0.30
thymus, fetal, pool1	10043-101F7	60.78	42.39	1.25	3.53	1.45	2.39	1.35	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.27	14.23	11.57	0.93	5.98	4.12	1.33	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	162.46	4.33	14.53	0.98	6.71	3.77	1.96	0.14
thyroid, adult, pool1	10028-101E1	6.07	14.37	0.28	3.64	0.19	0.00	0.09	0.47
thyroid, fetal, donor1	10060-101H6	12.92	21.09	1.58	7.38	1.05	0.26	1.05	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	12.32	3.08	0.00	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	44.42	4.19	2.33	1.86	0.70	0.70	0.00	0.23
tongue, fetal, donor1	10059-101H5	27.98	10.25	3.55	3.94	0.79	1.97	0.39	0.00
tonsil, adult, pool1	10047-101G2	35.46	22.34	0.30	2.40	0.90	1.50	0.80	0.10
trachea, adult, pool1	10029-101E2	12.68	8.92	0.25	1.72	0.16	0.16	0.16	0.25
trachea, fetal, donor1	10058-101H4	44.24	13.46	5.00	2.69	0.77	0.77	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	37.20	16.65	10.27	0.71	3.19	0.35	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	92.60	5.67	6.99	3.34	4.15	1.32	1.42	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	111.09	0.63	6.74	2.82	4.70	1.72	2.66	0.94
tridermal teratoma cell line:HGRT	10694-109G1	100.83	11.42	34.25	0.00	5.71	3.81	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	78.56	3.98	1.02	0.34	0.25	0.76	0.51	0.00
umbilical cord, fetal, donor1	10057-101H3	14.61	12.52	0.00	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	9.38	22.01	1.71	3.92	0.34	0.34	0.00	0.17
uterus, fetal, donor1	10055-101H1	33.28	8.70	5.12	6.14	1.54	0.51	1.02	0.00
vagina, adult	10204-103F6	21.32	15.51	1.29	5.82	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	22.36	22.36	0.66	1.32	1.10	0.22	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.21	8.81	0.00	0.00	0.00	1.07	0.27	0.00